Date,Agency,Category,Information
21. October 2024,European Commission,Update,,Notified Bodies Overview
21. October 2024,European Commission,Guidance,,MDCG 2021-25 rev.1 - Application of MDR requirements to "legacy devices"
21. October 2024,European Medicines Agency,Guidance,Applicants seeking access to PRIME scheme
21. October 2024,European Medicines Agency,Fachtsheet,PRIME Paving the way for promising medicines for patients
21. October 2024,European Medicines Agency,Plan,Change management - HMA-EMA joint Big Data Steering Group
21. October 2024,European Medicines Agency,Newsflash,CTIS newsflash â€“ 8. October 2024
21. October 2024,European Medicines Agency,Concept Paper,Clinical evaluation of therapeutic 4 radiopharmaceuticals in Oncology
21. October 2024,European Medicines Agency,Guidance,Registration guide for UI and API users
21. October 2024,European Medicines Agency,Guidance,Veterinary pharmacovigilance inspections
21. October 2024,European Medicines Agency,Guidance,Implementation of the European Pharmacopoeia Supplement 11.7
21. October 2024,"Health Sciences Authority (HSA),Singapore",Guidance,Post-marketing Vigilance Requirements for Therapautic Products
21. October 2024,"Health Sciences Authority (HSA),Singapore",Reimbursement	MediShield Life Councilâ€™s recommendations accepted - 2024 review
21. October 2024,ISO(International Organization for Standardization),Standard,ISO Update September 1. to 30. 2024
21. October 2024,Department of Health and Social Care,Roadmap,Design for Life Roadmap
21. October 2024,"MEDSAFE,New Zealand",Guidance,Requirements for information for prescribers and consumers
21. October 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements	2 medical device standards: "Brain-Computer Interface Technology".
21. October 2024,Swissmedic,Forms,Forms for October 2024
21. October 2024,Swissmedic,Guidance,Fast-track & Temporary authorisation procedure for human medicinal products
21. October 2024,Swissmedic,Guidance,Authorisation of medicinal gases
21. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Requesting the Minister for Health to reconsider our initial decision
21. October 2024,"Therapeutic Goods Administration (TGA)", Australia",Guidance,Our response to questions asked about the Essential Principles consultation
21. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Nitrosamine impurities acceptable intakes update - October 2024
21. October 2024,USA Food & Drug Administration FDA,Guidance,CDRH Proposed Guidances for Fiscal Year 2025 (FY2025)
21. October 2024,USA Food & Drug Administration FDA,Guidance,Endosseous Dental Implants and Endosseous Dental Implant Abutments
21. October 2024,USA Food & Drug Administration FDA,Guidance,Frequently Asked Questions about Labeling for Prescription Medicines
21. October 2024,USA Food & Drug Administration FDA,Guidance,Supersaturation to Support â€œUrinary Tract Healthâ€ claims for Adult  Cat Food
21. October 2024,USA Food & Drug Administration FDA,Guidance,Temporary Policies for Compounding Certain Parenteral Drug Products
21. October 2024,USA Food & Drug Administration FDA,Guidance,Requests for Reconsideration at the Division Level Under GDUFA
21. October 2024,USA Food & Drug Administration FDA,Guidance,FDA Releases Updated Biosimilar Curriculum Toolkit
21. October 2024,USA Food & Drug Administration FDA,Guidance,Long-Term Clinical Neurodev. Safety Studies - Neonatal Product Development
21. October 2024,USA Food & Drug Administration FDA,Regulation,QMSR Correction
21. October 2024,USA Food & Drug Administration FDA,Report,Accelerating Rare Disease Cures (ARC) Program Year Two Annual Report
21. October 2024,USA Food & Drug Administration FDA,Snapshots,Device Trial Participation Snapshots
21. October 2024,World Health Organisation WHO,Guidance,Patient navigation for early detection, diagnosis and treatment of breast cancer
14. October 2024,Drug Regulatory Authority of Pakistan,Guidance,Switch over from Web Based One Customs (WEBOC)
14. October 2024,Egyptian Drug Authority,Guidance,Preclinical testing and Clinical Investigation for Medical devices
14. October 2024,Egyptian Drug Authority,Guidance,Application for Reliance Pathway - Laboratory Testing of Medical Products
14. October 2024,European Commission,Guidance,MDCG 2024-12 Guidance & Templates for Conformity Assessment
14. October 2024,European Commission,Guidance,MDCG 2024-11 Guidance on qualification of in vitro diagnostic medical devices
14. October 2024,European Commission,Update,Notified Body Update (50) MDR & (13) IVDR
14. October 2024,European Commission,Regulation,Harmonised standard aseptic processing of health care products
14. October 2024,European Commission,Regulation,Harmonised standard aseptic processing health care products & clinical studies
14. October 2024,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure
14. October 2024,European Medicines Agency,Guidance,Implementation of ISO standards for (IDMP)
14. October 2024,European Medicines Agency,Guidance,"Mandate, objectives and rules of procedure GMP/GDP inspectors working group"
14. October 2024,European Medicines Agency,Updates,Veterinary Medicine. New Authorizations and Safety Updatesre
14. October 2024,European Medicines Agency,Consultation,Network strategy to 2028
14. October 2024,European Medicines Agency,Guidance,Overview of comments received on ICH M14
14. October 2024,European Directorate for the Quality of Medicines & HealthCare,Consultation,Pharmeuropa 36.4 just released
14. October 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report
14. October 2024,Health & Youth Care Inspectorate, Netherlands",Call for Action,Medical Device Manufacturers - Implement an effective PMS system
14. October 2024,International Pharmaceutical Excipients Council Federation (IPEC),Guidance,Good Distribution Practices (GDP)
14. October 2024,Medicines and Healthcare products Regulatory Agency,Plan,MHRA Corporate Plan 2023-26
14. October 2024,Medicines and Healthcare products Regulatory Agency,Plan,Business Plan 2024/25
14. October 2024,International Medical Device Regulators Forum,Meeting,"26th Meeting Seattle, Washington  - Outcome Statement"
14. October 2024,International Medical Device Regulators Forum,Guidance,Common Data Set for Adverse Event Data Exchange Between Regulators
14. October 2024,South African Health Products Regulatory Authority,Announcement,South African & Australian health to share regulatory information
14. October 2024,Swissmedic,Journal,Swissmedic Journal September 2024
14. October 2024,Swissmedic,Corrigendûm,Reprocessing of Medical Devices
14. October 2024,Swissmedic,Annual Report,Potential for improvement in hospitals
14. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising to health professionals
14. October 2024,USA Food & Drug Administration FDA,Roadmap,Women’s Health Research Roadmap
14. October 2024,USA Food & Drug Administration FDA,Guidance,Pharmaceutical Quality/Chemistry Manufacturing and Controls (PQ/CMC)
14. October 2024,USA Food & Drug Administration FDA,Podcast,Considerations of Drug Products that Contain Nano Materials
14. October 2024,USA Food & Drug Administration FDA,Exemption,FDA Grants Exemption to Connected Trading Partners
7. October 2024,ANVISA Brazil,Announcement,Anvisa and USA FDA sign Confidentiality Agreement
7. October 2024,European Medicines Agency,Guidance,Guidance on the details of the classification of variations veterinary products
7. October 2024,European Medicines Agency,Reflection paper,Artificial Intelligence (AI) in the medicinal product lifecycle
7. October 2024,European Medicines Agency,Guidance,Risk management for elemental impurities in veterinary medicinal products V3
7. October 2024,European Medicines Agency,Guidance,"Quality and equivalence of locally applied, locally acting cutaneous products"
7. October 2024,European Medicines Agency,Guidance,Overview of comments received on quality and equivalence of topical products
7. October 2024,European Medicines Agency,Guidance,Q&A low global warming potential propellants pressurised metered dose inhalers
7. October 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee 30 September-3 October 2024
7. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product
7. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for manufacturer or wholesaler of medicines licences
7. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Pre-submission Advice & Support
7. October 2024,Department of Health The Government of the Hong Kong,Guidance,New arrangement of Processing of Renewal Application of Listed Medical Device
7. October 2024,Swissmedic,Deadline,swissdamed: Deadline on 13 November 2024
7. October 2024,Swissmedic,Guidance,Summary report on authorisation
7. October 2024,Swissmedic,Guidance,Transfer of marketing authorisation
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Understanding product standards for unapproved therapeutic vapes in Australia
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Guidance supporting updated MDSO instrument
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Special Access Scheme (SAS): Accessing unapproved therapeutic goods
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Product standards: unapproved therapeutic vapes
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Updates,Updates to the Prescribing Medicines in Pregnancy database - September 2024
7. October 2024,Ministry of Health Türkiye,Guidance,"Sale, Advertising, and Promotion of Medical Devices"
7. October 2024,USA Food & Drug Administration FDA,Guidance,Dental Impression Materials –Criteria for Safety & Performance
7. October 2024,USA Food & Drug Administration FDA,Guidance,Dental Ceramics – Criteria for Safety & Performance
7. October 2024,USA Food & Drug Administration FDA,Guidance,Dental Cements - Criteria for Safety & Performance
7. October 2024,USA Food & Drug Administration FDA,Guidance,Air Powered Dental Handpieces & Motors Criteria for Safety & Performance
7. October 2024,USA Food & Drug Administration FDA,Guidance,Studies to Evaluate Residues of Veterinary Drugs in Human Food
7. October 2024,USA Food & Drug Administration FDA,Report,CDER’s Office of Medical Policy 2023 Annual Report
7. October 2024,USA Food & Drug Administration FDA,Report,GDUFA Outcomes Support Development and Evaluation of Generic Drugs
7. October 2024,USA Food & Drug Administration FDA,Guidance,"Q&A Electronic Systems, Records, and Signatures in Clinical Investigations"
7. October 2024,USA Food & Drug Administration FDA,Guidance,Total Product Life Cycle Advisory Program (TAP) Engagement Tips
7. October 2024,USA Food & Drug Administration FDA,Updated,Total Product Life Cycle Advisory Program (TAP)
7. October 2024,USA Food & Drug Administration FDA,Snapshot,Clinical Pharmacology Considerations - Radiolabeled Mass Balance Studies
7. October 2024,World Health Organisation WHO,Report,Responsible use of the life sciences and dual-use research
7. October 2024,World Health Organisation WHO,Guidance,Guidance for best practices for clinical trials
30. September 2024,ANVISA Brazil,Regulation,"925 Manufacture, marketing, import, of customized medical devices"
30. September 2024,ANVISA Brazil,Regulation,909 Registration of products in development or technology transfer
30. September 2024,"East Africa Regulatory Affairs Association (EARAPA) NDA, Uganda",Circular,Fast-track Assessment of Variations (Ammendments) & CTD Dossier Applications.
30. September 2024,Egyptian Drug Authority,Update,Technical Committee for Drug Control on 8/8/2024 on biopharmaceuticals
30. September 2024,Egyptian Drug Authority,Announcement,Important announcement for importers of dental implants
30. September 2024,Egyptian Drug Authority,Guidance,Release of Biological Preparations
30. September 2024,Egyptian Drug Authority,Guidance,"Non-commercial samples of medical, laborator, diagnostic supplies & devices"
30. September 2024,Egyptian Drug Authority,Tool,EDA API Searching Tool
30. September 2024,European Commission,Guidance,Validity of clinical studies for joint clinical assessments
30. September 2024,European Commission,Guidance,MDCG 2021-4 rev.1 - transitional provisions class D IVDR
30. September 2024,European Medicines Agency,Guidance,Guide to information on human medicines evaluated by EMA
30. September 2024,European Medicines Agency,Guidance,QRD statements-metered dose inhalers containing fluorinated greenhouse gases
30. September 2024,European Medicines Agency,Newsflash,CTIS newsflash – 24. September 2024
30. September 2024,European Medicines Agency,Guidance,Compilation of Union procedures on inspections and exchange of information
30. September 2024,European Medicines Agency,Guidance,Important medical event terms list (MedDRA version 27.1)
30. September 2024,European Medicines Agency,Guidance,List of eligible industry stakeholder organisations
30. September 2024,European Medicines Agency,Guidance,Advice on substances essential for the treatment of equine species
30. September 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Specification Package v1.0 for Electronic Common Technical Document (eCTD)
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,AI Airlock: the regulatory sandbox for AIaMD
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical investigations guidance
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Initiatives
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply to release a vaccine or a blood product to market
30. September 2024,Medical Dictionary for Regulatory Activities,Guidance,MedDRA Latest Versions and Support Documentation
30. September 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Guideline for Akkermansia muciniphila strain ATCC BAA-835
30. September 2024,USA Food & Drug Administration FDA,Guidance,The Accreditation Scheme for Conformity Assessment (ASCA) Program
30. September 2024,USA Food & Drug Administration FDA,Guidance,Biocompatibility Testing of Medical Devices –(ASCA) Program
30. September 2024,USA Food & Drug Administration FDA,Guidance,Safety and Essential Performance of Medical Electrical Equipment (ASCA)
30. September 2024,USA Food & Drug Administration FDA,Report,FDA Information Technology Strategy for Fiscal Years 2024 to 2027
30. September 2024,USA Food & Drug Administration FDA,Guidance,Circular of Information for the Use of Human Blood and Blood Components
30. September 2024,USA Food & Drug Administration FDA,Guidance,FDA Digital Health and Artificial Intelligence Glossary
30. September 2024,USA Food & Drug Administration FDA,Proposed Rule,"Reclassification Antigen, Antibody, & Nucleic Acid-Based Hepatitis B Assays"
30. September 2024,USA Food & Drug Administration FDA,Guidance,Radiation Control Regulations For Manufacturers of Diagnostic X-Ray Equipment
30. September 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies
23. September 2024,Drug Regulatory Authority of Pakistan,Guidance,Guidelines on National Pharmacovigilance System (Edition 03)
23. September 2024,Egyptian Drug Authority,Guidance,Good Control Practices for Clinical Research
23. September 2024,European Commission,Corrigendum,Horizontal Cybersecurity Requirements for Products with Digital Elements
23. September 2024,European Medicines Agency,Notice,European Medicines Agency’s RMS Data Protection Notice
23. September 2024,European Medicines Agency,Guidance,Environmental risk assessment of medicinal products for human use
23. September 2024,European Medicines Agency,Report,Early dialogue with healthcare professional organisations for marketing authorisation
23. September 2024,European Medicines Agency,Guidance,"How to create, submit and manage IRIS applications"
23. September 2024,European Medicines Agency,Meeting,"Clinical Trials Regulation (CTR) Collaborate Stakeholder meeting, ACT EU"
23. September 2024,European Medicines Agency,Guidance,Guidance for competent authorities on how to highlight VNRAs
23. September 2024,European Medicines Agency,Paper,Efficacy based on single arm trials submitted as evidence for marketing authorisation
23. September 2024,European Medicines Agency,Guidance,Pharmaceutical Risk Assessment Committee criteria to prioritise impact research
23. September 2024,European Medicines Agency,Survey,SME Survey 2024
23. September 2024,European Medicines Agency,Guidance,Q&A labelling requirements for centrally authorised metered dose inhalers
23. September 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2024
23. September 2024,European Medicines Agency,Guidance,CTIS Evaluation Timelines
23. September 2024,European Union Agency for Cybersecurity (ENISA),Report,ENISA Threat Landscape 2024
23. September 2024,"Health Sciences Authority (HSA), Singapore",Consultatiion,"""SHARE"": Your one stop digital portal for Class 2 CTGTP Registration"
23. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Wholesalers & manufacturers guidance - Windsor Framework
23. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Established medicines: marketing authorisation application changes
23. September 2024,Medicines and Healthcare products Regulatory Agency,Policy,MHRA Strategy for Improving Safety Communications
23. September 2024,"Team Notified Body, Europe",Guidance,Team-NB Code of Conduct for Notified Bodies V5
23. September 2024,Swissmedic,News,New implementing regulations for submitting Clinical Research Applications
23. September 2024,Swissmedic,Guidance,Request to review devices that comply with the old legislation
23. September 2024,Swissmedic,Guidance,Go-live of the SwissGMDP database
23. September 2024,Swissmedic,Form,Gesuch Verzicht Betriebsbewilligung Arzneimittel (inkl. Blut) / TpP/GT/GVO)
23. September 2024,USA Food & Drug Administration FDA,News,FDA Authorizes First Over-the-Counter Hearing Aid Software
23. September 2024,USA Food & Drug Administration FDA,Guidance,Clinical Evidence from Oncology Multiregional Clinical Development Programs
23. September 2024,USA Food & Drug Administration FDA,Guidance,Study Data Technical Conformance Guide - Technical Specifications Document
23. September 2024,USA Food & Drug Administration FDA,Guidanec,Data Standards Catalog
23. September 2024,USA Food & Drug Administration FDA,Guidance,"Chemistry, Manufacturing, & Controls (CMC) Technical Section Filing Strategies"
23. September 2024,USA Food & Drug Administration FDA,Guidance,Conducting Clinical Trials With Decentralized Elements
23. September 2024,USA Food & Drug Administration FDA,Guidance,Randomized Controlled Trials for Drug and Biological Products
23. September 2024,USA Food & Drug Administration FDA,Database,"Approved Drug Products with Therapeutic Equivalence Evaluations, Orange Book"
23. September 2024,USA Food & Drug Administration FDA,Guidance,Chemical Analysis for Biocompatibility Assessment of Medical Devices
16. September 2024,ANVISA Brazil,Regulation,"RESOLUTION RDC NO. 903, Procedures for the transfer of ownership"
16. September 2024,CDSCO India,Guidance,Draft Guidelines on Good Clinical Practice
16. September 2024,European Commission,Guidance,Data Act Explained
16. September 2024,European Commission,Report,The future of European Competitiveness
16. September 2024,European Commission,Update,Notified Body Update MDR & IVDR
16. September 2024,European Medicines Agency,Meetiing,Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2024
16. September 2024,European Medicines Agency,Guidance,"Clinical development, medicinal products. treatment & prevention bipolar disorder"
16. September 2024,European Medicines Agency,Guidance,Info session on web-based electronic Application Form (eAF) add package
16. September 2024,European Medicines Agency,Newsflash,CTIS newsflash – 10 September 2024
16. September 2024,European Medicines Agency,Guidance,Biological and chemical threats
16. September 2024,European Medicines Agency,Guidance,Q&A regarding co-processed excipients used in solid oral dosage forms
16. September 2024,ISO (International Organization for Standardization),Standard,"ISO Update August 1, 2024 to August 31, 2024"
16. September 2024,International Medical Device Regulators Forum,Report,IMDRF Document Implementation Report
16. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines Pipeline data
16. September 2024,Medicines and Healthcare products Regulatory Agency,Consultation,MHRA consultation on statutory fees
16. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Early Access to Medicines Scheme - Information for Applicants
16. September 2024,South African Health Products Regulatory Authority,Form,Medical Device Manufacture Licence
16. September 2024,South African Health Products Regulatory Authority,Guidance,Renewal of Human and Veterinary Medicines Requirements and Process
16. September 2024,"Team Notified Body, Europe",Position Paper,Transfer Agreement for Surveillance of Legacy Devices IVD
16. September 2024,"Team Notified Body, Europe",Position Paper,Team-NB Position Paper list (update September 11th 2024))
16. September 2024,Swissmedic,Directory,List Countries with recognised GMP control systems
16. September 2024,Swissmedic,Guidance,Electronic exchange of ICSRs in E2B(R3) format through B2B gateway
16. September 2024,Swissmedic,Form,Meldung unerwünschter Tierarzneimittelwirkungen Synthetika oder Impfstoffe
16. September 2024,Swissmedic,Form,Schengen Certificate
16. September 2024,USA Food & Drug Administration FDA,Guidance,Withdrawn Guidances (Biologics)
16. September 2024,USA Food & Drug Administration FDA,Guidance,Appeal Options to Mammography Facilities  Adverse Accreditation Decisions
16. September 2024,USA Food & Drug Administration FDA,Guidance,Amendments to Abbreviated New Drug Applications ANDA Under GDUFA
16. September 2024,USA Food & Drug Administration FDA,Guidance,Providing Regulatory Submissions in Electronic Format (eCTD)
16. September 2024,USA Food & Drug Administration FDA,Guidance,Formal Meetings and Requests for Feedback for CBER-Regulated Products
16. September 2024,USA Food & Drug Administration FDA,Final Rule,Mammography Quality Standards Act (MQSA)
16. September 2024,USA Food & Drug Administration FDA,Classification,Medical Devices; Immunology and Microbiology Devices; Exome Sequencing
16. September 2024,USA Food & Drug Administration FDA,Standard,Three additional standards to advance innovation in sterilization processes
16. September 2024,World Health Organisation WHO,Guidance,Implementation toolkit for accessible telehealth services
9. September 2024,Egyptian Drug Authority,Guidance,Time limit granted to bulletins in which Safety Update occurs
9. September 2024,Egyptian Drug Authority,Guidance,Requirements for variable files submitted to General Directorate of Stability
9. September 2024,Egyptian Drug Authority,Guidance,Transfer / addition of the place of primary and secondary packaging
9. September 2024,Egyptian Drug Authority,Guidance,Endocrine part of the Egyptian drug registry manufacturing)
9. September 2024,Egyptian Drug Authority,Guidance,Role of Oncology Pharmacists in Radiation Therapy
9. September 2024,European Medicines Agency,Notice,Data Protection Notice for EudraVigilance Human (EV)
9. September 2024,European Medicines Agency,Standard Operating Procedure,"For assignment of micro-, small- or medium-sized-enterprise"
9. September 2024,European Medicines Agency,Guidance,AI in medicines regulation: use of large language models (LLMs)
9. September 2024,European Directorate for the Quality of Medicines & HealthCare,News,PDG announces global membership initiative
9. September 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report August 2024
9. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Ionising Radiation (Medical Exposure) Regulations 2017
9. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
9. September 2024,"MEDSAFE, New Zealand",Journal,Prescriber Update Vol. 45. No. 3 - September 2024
9. September 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements,"Pediatric Chemical Food, Cough, and Asthma Preparations (No. 106)"
9. September 2024,Saudi Food & Drug Authority,Guidance,(GVP) Specific Considerations II: Pregnant and breastfeeding women
9. September 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,3 International Scientific Guidelines Adopted by TGA since 2. September 2024
9. September 2024,Swissmedic,Form,Mobile technologies – Submission of films
9. September 2024,Swissmedic,Guidance,Marketing / interruption of distribution for veterinary medicinal products
9. September 2024,Swissmedic,Guidance,Electronic data sets from pivotal bioequivalence studies
9. September 2024,Swissmedic,Guidance,Packaging texts for veterinary medicinal products
9. September 2024,Swissmedic,Guidance,SEND data sets for new authorisation human medicinal products with new API
9. September 2024,Swissmedic,Guidance,Combined Studies
9. September 2024,Swissmedic,Guidance,Accompanying documentation authorisation and variation for medicinal products
9. September 2024,Swissmedic,Guidance,Changes to the guidance document Time limits for authorisation applications
9. September 2024,Swissmedic,Guidance,Export Certificates
9. September 2024,Swissmedic,Journal,Swissmedic Journal August 2024
9. September 2024,National Institute of Standards and Technology (NIST),Blog,Cybersecurity Insights
9. September 2024,USA Food & Drug Administration FDA,Guidance,Bioresearch Monitoring Technical Conformance Guide
9. September 2024,USA Food & Drug Administration FDA,Guidance,Control of Nitrosamine Impurities in Human Drugs
9. September 2024,USA Food & Drug Administration FDA,News,Whole Genome Sequencing (WGS) Program
9. September 2024,USA Food & Drug Administration FDA,Guidance,Voluntary Patient Preference Information over the Total Product Life Cycle:
9. September 2024,World Health Organisation WHO,Guidance,WHO updates laboratory biosecurity guidance
2. September 2024,Egyptian Drug Authority,Guidance,Changes mentioned in the deadline letters not proven in the medical requirement
2. September 2024,Egyptian Drug Authority,Support,Technical support links for the Cosmetics Listing Platform EgyCosm
2. September 2024,European Medicines Agency,Guidance,ICH guideline E11A on pediatric extrapolation Step 5
2. September 2024,European Medicines Agency,Guidance,Compilation of union procedures on inspections and exchange of information
2. September 2024,"Health Sciences Authority (HSA), Singapore",Consultatiion,Guidance on Change Management Program (CMP) for SaMD
2. September 2024,International Council for Harmonisation,Guidance,The ICH E11A Guideline reaches Step 4 of the ICH Process
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical trials for medicines: apply for authorisation in the UK
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Quarterly Reports – guidance and template for manufacturers / sponsors
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework for Medicines comes into effect 1. January 2025
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Pharmacovigilance following agreement of the Windsor Framework
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,UK-wide licensing for human medicines
2. September 2024,Medicines and Healthcare products Regulatory Agency,Consultation,Consultation on the International Council for Harmonisation (ICH) M14
2. September 2024,Medicines and Healthcare products Regulatory Agency,Consultation,MHRA consultation on statutory fees
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure
2. September 2024,"MEDSAFE, New Zealand",Consultation,Regulation of Therapeutic Products in New Zealand: Clinical Trials
2. September 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Scientific Guidelines Adopted by TGA from the EU
2. September 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Submission of the Clinical Trial application CTA
2. September 2024,Swissmedic,Requirements,Responsible Person
2. September 2024,Swissmedic,Guidance,Electronic exchange of ICSRs in E2B(R3) format through B2B gateway
2. September 2024,Swissmedic,Guidance,Electronic exchange of ICSRs in E2B(R2) format through PV Gateway
2. September 2024,Swissmedic,Form,For application under Art. 13 TPA VMP
2. September 2024,Swissmedic,Form,Formular Gesuch Herstellerangaben Nichtstandardisierbare AM/TpP
2. September 2024,National Institute of Standards and Technology (NIST),Guidance,NIST Releases Second Public Draft of Digital Identity Guidelines for Final Review
2. September 2024,USA Food & Drug Administration FDA,Fees,Biosimilar User Fee Amendments
2. September 2024,USA Food & Drug Administration FDA,Guidance,MDR Enhancements
2. September 2024,USA Food & Drug Administration FDA,Reporting Program,Voluntary Malfunction Summary Reporting Program
2. September 2024,USA Food & Drug Administration FDA,Guidance,Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers
2. September 2024,USA Food & Drug Administration FDA,Hub,OMHHE Enhance Equity Research Hub
2. September 2024,USA Food & Drug Administration FDA,Educational Materials,Multimedia Education Materials | Biosimilars
2. September 2024,USA Food & Drug Administration FDA,Webinar,"IVDs - MDR Requirements, Correction. Removal Reporting, & QMS Requirements"
26. August 2024,Egyptian Drug Authority,Guidance,Update on the Mechanisms for Submitting and Evaluating Stability Studies
26. August 2024,European Commission,Update,Notified Body Update MDR & IVDR
26. August 2024,European Commission,Consultation,Ammendment (EU) 2022/1107 Common specifications for class D IVD
26. August 2024,European Medicines Agency,Guidance,Plasma Master File (PMF) submissions
26. August 2024,European Medicines Agency,Guidance,Clinical Trial Information System Sponsor Handbook
26. August 2024,European Medicines Agency,Guidance,Good pharmacovigilance practices (GVP)
26. August 2024,ISO (International Organization for Standardization),Standard,"ISO Update July 1, 2024 to July 31, 2024"
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for the early access to medicines scheme (EAMS)
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Good laboratory practice (GLP) for safety tests on chemicals
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,AI Airlock: the regulatory sandbox for AIaMD
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active UK substances for use in EEA and Northern Ireland
26. August 2024,Medical Device Authority Malaysia,Update,Medical Devices with Expired EC Certificates and Self Declared Class B IVD
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidelines,17. International Scientific Guidelines Adopted from the EU
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",News,Sponsors and manufacturers reminded about upcoming financial deadlines
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",News,Post-market review of spinal cord stimulator devices
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Essential Principles checklist
26. August 2024,Swissmedic,Information Sheet,3D printers medical devices
26. August 2024,USA Food & Drug Administration FDA,Fees,FY 2025 PDUFA Program Fee Invoices and Rates
26. August 2024,USA Food & Drug Administration FDA,Guidance,Product-Specific Guidance Meetings Between FDA and ANDA Applicants GDUFA
26. August 2024,USA Food & Drug Administration FDA,Guidance,Frequently Asked Questions Quality Management System Regulation
26. August 2024,USA Food & Drug Administration FDA,Guidance,Predetermined Change Control Plans or Medical Devices
26. August 2024,USA Food & Drug Administration FDA,Guidance,Acceptable Media for Electronic Product User Manuals
26. August 2024,USA Food & Drug Administration FDA,Guidance,FAQ CDER Center for Clinical Trial Innovation (C3TI)
26. August 2024,USA Food & Drug Administration FDA,Guidance,Electronic Submission Template for Medical Device De Novo Requests
26. August 2024,USA Food & Drug Administration FDA,Guidance,Title: FDA and Industry Procedures for Section 513(g) Requests for Information
26. August 2024,USA Food & Drug Administration FDA,Guidance,FDA Drug Recall Process Snapshot
26. August 2024,USA Food & Drug Administration FDA,Guidance,Product-Specific Guidances for Generic Drug Development
26. August 2024,USA Food & Drug Administration FDA,Guidance,Mammography Quality Standards Act & Regulation Amendments
26. August 2024,Association for the Advancement of Medical Instrumentation AAMI,Guidance,New Consensus on the Sterilization of Single-Use Systems for Manufacturing
26. August 2024,World Health Organisation WHO,Publication,"WHO Drug Information, Volume 38, Number 2, 2024"
26. August 2024,World Health Organisation WHO,Publication,WHO Expert Committee on Biological Standardization: seventy-ninth report
19. August 2024,CDSCO India,Guidance,Draft Guidelines on Good Distribution Practices for Pharmaceutical Products
19. August 2024,Egyptian Drug Authority,Guidance,Updating the categories of medical supplies allowed to obtain annual import plans
19. August 2024,Egyptian Drug Authority,Guidance,Good Regulatory Oversight of Clinical Trials by Egyptian Drug Authority
19. August 2024,Egyptian Drug Authority,Guidance,Transfer of the type of registered pharmaceuticals
19. August 2024,European Commission,Report,Cyber security in the health and medicine sector:
19. August 2024,European Medicines Agency,Guidance,Biological and chemical threats
19. August 2024,European Medicines Agency,Guidance,"Q&A, Mutual Recognition Agreement (MRA) between the EU and the USA"
19. August 2024,European Medicines Agency,Guidance,FAQs How to manage a clinical trials
19. August 2024,European Medicines Agency,Guidance,"FAQs How to create, submit and withdraw a CTA"
19. August 2024,European Medicines Agency,Guidance,Step-by-step guide Supervise a CT – Ad Hoc Assessment
19. August 2024,European Medicines Agency,Guidance,Instructor’s Guide: Supervise a CT Ad Hoc Assessment
19. August 2024,European Medicines Agency,Guidance,FAQs Supervise a CT – Ad Hoc Assessment
19. August 2024,European Medicines Agency,Guidance,FAQs Transitional trials from EudraCT to CTIS
19. August 2024,European Medicines Agency,Guidance,Quick guide Transitional trials from EudraCT to CTIS (sponsor users)
19. August 2024,European Medicines Agency,Guidance,Clinical Trial Information System Sponsor Handbook
19. August 2024,European Medicines Agency,Guidance,Guide to CTIS Training Catalogue
19. August 2024,IEEE Standards Association | IEEE SA,Standards,Notice of New Standard Product IEEE/ISO 11073-10206-2024
19. August 2024,IEEE Standards Association | IEEE SA,Paper,Key Parameters for Identifying Electronic Health Records without Violating Privacy
19. August 2024,Ministry of Food and Drug Safety of Republic of Korea,Regulation,Regulations on In Vitro Diagnostic Medical Device and Classification
19. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Pre-submission Advice & Support
19. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines Pipeline data
19. August 2024,Department of Health The Government of the Hong Kong,Guidance,Classification of General Medical Devices (TR-003)
19. August 2024,Swissmedic,Information Sheet,Klassierung und Abklärung von Transfusionsreaktionen
19. August 2024,Swissmedic,Information Sheet,Haemovigilance - Nebenwirkungen bei Blutspenden
19. August 2024,Swissmedic,Information Sheet,Reporting quality defects in labile blood products
19. August 2024,Swissmedic,Information Sheet,Non-standardised medicinal products and medicinal product groups
19. August 2024,Swissmedic,Transitional Provisions,EU IVDR Equivalence with EU Regulation on Medical Devices
19. August 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Australian Medical Device Essential Principles - Alignment with the EU
19. August 2024,National Institute of Standards and Technology (NIST),Standards,First 3 Finalized Post-Quantum Encryption Standards
19. August 2024,USA Food & Drug Administration FDA,Consultation,FDA IT Strategy for FY 2024 – FY 2027
12. August 2024,CDSCO India,Circular,Implementation of Schedule M and WHO Technical Report Serie
12. August 2024,Egyptian Drug Authority,Guidance,Lot Release of Biological Products in Egypt
12. August 2024,European Commission,Regulation,Designation of EU UDI issuing entities
12. August 2024,European Commission,EUDAMED,Release note v3.9.0
12. August 2024,European Medicines Agency,Guidance,ICH Guideline M13A on bioequivalence for immediate release solid dosage forms
12. August 2024,European Medicines Agency,Guidance,ICH E2D Post-approval safety data management - Scientific guideline
12. August 2024,European Medicines Agency,Guidance,ICH reflection paper on real-world data to generate real world evidence
12. August 2024,European Medicines Agency,Arrangement,Joint Controllership Arrangement - Union product database (UPD)
12. August 2024,European Medicines Agency,Guidance,Good pharmacovigilance practices (GVP) 5 Revisions
12. August 2024,European Medicines Agency,List,Union list of critical medicines: EudraVigilance Dictionary (XEVMPD)
12. August 2024,European Medicines Agency,Guidance,Clinical Trial Information System (CTIS) - Sponsor handbook
12. August 2024,European Medicines Agency,Guidance,"FAQ, Substance and product data management services"
12. August 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report July 2024
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Register medical devices to place on the market
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Export medical devices
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active UK substances for use in EEA and Northern Ireland
12. August 2024,Department of Health The Government of the Hong Kong,Guidance,Various Guidance Notes and Code of Practice have been updated
12. August 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Inspection of Medical Device Business Quality Management Standards
12. August 2024,Swissmedic,Guidance,Swissdamed
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Disinfectants, sterilants and sanitary products"
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Changes to the Permissible Ingredients Determination
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device conformity assessment application
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Should your product be in the ARTG
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Varying entries in the ARTG: medical devices and IVDs
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Access Generic Medicines work-sharing initiative operational procedures update
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Application to amend the Poisons Standard
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Business Plan 2024-25
12. August 2024,USA Food & Drug Administration FDA,Discussion Paper,Health Equity For Medical Devices
12. August 2024,USA Food & Drug Administration FDA,Guidance,MDSAP Audit Approach
12. August 2024,USA Food & Drug Administration FDA,Plan,Language Access Plan
12. August 2024,USA Food & Drug Administration FDA,Guidance,Optimizing the Dosage of Drugs and Biologics for Oncology Treatment
12. August 2024,USA Food & Drug Administration FDA,Guidance,Developing drugs for treatment of Unresponsive Nonmuscle Bladder Cancer
5. August 2024,CDSCO India,Circular,Circular regarding Requirement of Toxicity Studies for New Drugs SNDs and FDCs
5. August 2024,Egyptian Drug Authority,Guidance,Procedures for issuing a replacement for lost / damaged permit
5. August 2024,European Medicines Agency,Newsflash,CTIS newsflash – 26 July 2024
5. August 2024,European Medicines Agency,Report,Real-world evidence framework to support EU regulatory decision-making
5. August 2024,European Medicines Agency,Infosheet,Review of real-world data studies
5. August 2024,European Medicines Agency,Guidance,Compilation of Union procedures on inspections
5. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure
5. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Initiatives
5. August 2024,Medicines and Healthcare products Regulatory Agency,Report,Human Medicines Regulations 2012 Advisory Bodies Annual Report 2023
5. August 2024,Medicines and Healthcare products Regulatory Agency,Report,British Pharmacopoeia Commission Annual Report 2023
5. August 2024,Medicines and Healthcare products Regulatory Agency,Report,MHRA Annual Report and Accounts
5. August 2024,"Health Sciences Authority (HSA), Singapore",Updates,Regulatory Updates for Therapeutic Product Registration (effective 1 Aug 2024)
5. August 2024,"Health Sciences Authority (HSA), Singapore",Updates,Guidance documents for therapeutic products
5. August 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Expedited Approval Scheme for Medical Device Listing Applications
5. August 2024,Medical Device Authority Malaysia,Updates,Pilot Survey for Unique Device Identification (UDI) In Malaysia
5. August 2024,Swissmedic,Guidance,Terms of Reference - Round Table on Medical Technology
5. August 2024,Swissmedic,Guidance,Ph.Helv. / Anforderungen / Phyto
5. August 2024,Swissmedic,Guidance,Anforderungen PhHelv KomplMedAM
5. August 2024,Swissmedic,Guidance,Handbuch HOMANT Offline 2.4.7.
5. August 2024,Swissmedic,Guidance,HB Handbuch HOMANT Asia
5. August 2024,Swissmedic,Guidance,Code of Conduct: members of the Swissmedic Medicines Expert Committees
5. August 2024,Swissmedic,Guidance,Packaging for human medicinal products
5. August 2024,National Institute of Standards and Technology (NIST),Guidance,Secure Software Development Practices for Generative AI
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Essential Principle 13B guidance
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulation of software based medical devices
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adoption of 13 international guidelines
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Nitrosamine impurities acceptable intakes update
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Submitting a Drug Master File (DMF)
5. August 2024,USA Food & Drug Administration FDA,Report,Office of Surveillance and Epidemiology 2023 Annual Report
5. August 2024,USA Food & Drug Administration FDA,Report,Office of New Drugs (OND) Research Outcomes Report FY2022-23
5. August 2024,USA Food & Drug Administration FDA,Fees,"OTC Monograph Order Request (OMOR), Medical Device User Fees"
5. August 2024,USA Food & Drug Administration FDA,Guidance,"M12 Drug Interaction Studies, Q&A M12 Drug Interaction Studies"
5. August 2024,USA Food & Drug Administration FDA,Guidance,Reprocessing Single-Use Medical Devices: Information for Health Care Facilities
5. August 2024,USA Food & Drug Administration FDA,SOPP,8426: Assignment of Biological & Drug Product Proper Names & Biological Suffixes
29. July 2024,Egyptian Drug Authority,Guidance,Unified link / electronic portal for all submission links to  Directorate of Stability
29. July 2024,Egyptian Drug Authority,Guidance,Requirements for delivering samples to the General Directorate of Evaluation
29. July 2024,Egyptian Drug Authority,Guidance,Monitoring the quality of biologicals after marketing
29. July 2024,Egyptian Drug Authority,Guidance,Mechanisms of the regulatory guide for the rules for implementing
29. July 2024,European Medicines Agency,Guidance,Chapter 3.II: XEVPRM User Guidance
29. July 2024,European Medicines Agency,Guidance,Development and Manufacture of Oligonucleotides
29. July 2024,European Medicines Agency,Statement,International collaboration - real-world evidence (RWE) for regulatory decisions
29. July 2024,European Medicines Agency,Guidance,Guideline on the chemistry of active substances
29. July 2024,European Medicines Agency,Concept paper,Guideline for demonstration of therapeutic equivalence for nasal products
29. July 2024,European Medicines Agency,Meeting,Highlights Committee for Medicinal Products for Human Use 22-25 July 2024
29. July 2024,Health Canada,Consultation,Proposed changes to the guidance on recognized standards
29. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Good clinical practice for clinical trials
29. July 2024,South African Health Products Regulatory Authority,Guidance,Guideline for the API Master File (APIMF) Procedure
29. July 2024,South African Health Products Regulatory Authority,Consultation,2.21 ZA-SAHPRA eCTD Specifications v3.1
29. July 2024,Swissmedic,Guidance,Electronic exchange of ICSRs through PV Gateway
29. July 2024,Swissmedic,Guidance,Swiss Module 1 Specification for eCTD Version 1.5
29. July 2024,Swissmedic,Guidance,Online help for the MD publication service
29. July 2024,Swissmedic,Guidance,Incident report user
29. July 2024,Swissmedic,Guidance,Medical devices FAQs Patients
29. July 2024,Swissmedic,Guidance,Vigilance contact person for medical devices
29. July 2024,Swissmedic,Guidance,Out-of-Stock Situation
29. July 2024,Swissmedic,Form,Declaration of interests and Confidentiality Swissmedic Medicines Expert Committee
29. July 2024,Swissmedic,Form,Einfuhr von immunologischen Arzneimittelnoder oder von Blut und Blutprodukten
29. July 2024,Swissmedic,Form,Application for Temporary Authorization
29. July 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Proposed changes to the regulation of assistive technologies
29. July 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Revision of the guidance document TGA Instructions for Disinfectant Testing
29. July 2024,USA Food & Drug Administration FDA,Guidance,Postapproval Manufacturing Changes to Biosimilar Products Q&A
29. July 2024,USA Food & Drug Administration FDA,Guidance,Recommendations for COVID-19 Convalescent Plasma
29. July 2024,USA Food & Drug Administration FDA,SOPP,SOPP 8101.1: Meetings with Sponsors and Applicants for Drugs & Biologics
29. July 2024,USA Food & Drug Administration FDA,Guidance,Real-World Data: Electronic Health Records & Claims Data to Support Decisions
29. July 2024,USA Food & Drug Administration FDA,Guidance,Container Closure System and Component Changes: Glass Vials and Stoppers.
29. July 2024,USA Food & Drug Administration FDA,Guidance,Providing Over-the-Counter Monograph Submissions in Electronic Format
29. July 2024,USA Food & Drug Administration FDA,Seeking Comment,Immunogenicity Risk of Host Cell Proteins in Recombinant Peptides
29. July 2024,USA Food & Drug Administration FDA,Seeking Comment,Biosimilar Product Development Guidance
29. July 2024,USA Food & Drug Administration FDA,Guidance Snapshot,Digital Health for Remote Data Acquisition in Clinical Investigations
29. July 2024,World Health Organisation WHO,Publication,Improving access to medicines for neurological disorders
22. July 2024,Egyptian Drug Authority,Guidance,Procedures of scientific advice for biological products
22. July 2024,European Commission,Regulation,New EU rules on substances of human origin
22. July 2024,European Medicines Agency,News,: CTIS newsflash - 12 July 2024
22. July 2024,European Medicines Agency,Q&A,Q2 2024 System Demo
22. July 2024,European Medicines Agency,Guidance,EMA EudraVigilance Registration Manual
22. July 2024,European Medicines Agency,Guidance,EudraVigilance - EVWEB User Manual
22. July 2024,European Medicines Agency,Guidance,Addendum clinical tials of vaccines in immunocompromised subjects
22. July 2024,European Directorate for the Quality of Medicines & HealthCare,Seeking Assistance,Ph. Eur. seeks feedback on the use of plastic additive 18
22. July 2024,ISO (International Organization for Standardization),Standard,"ISO Update June 1, 2024 to June 30, 2024"
22. July 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements,Temporary Import and Use of Medical Devices Urgently for Clinical Use
22. July 2024,Department of Health The Government of the Hong Kong,MDACS,Medical Device Information System
22. July 2024,Department of Health The Government of the Hong Kong,Guidance,Classification of In Vitro Diagnostic Medical Devices (IVDMDs) (TR-006)
22. July 2024,Department of Health The Government of the Hong Kong,Guidance,Guidance Notes for Changes of Listed Medical Devices (GN-10)
22. July 2024,MedTech Europe,Template,Manufacturer’s Declaration in relation to Regulation (EU) 2024/1860
22. July 2024,MedTech Europe,Report,Facts & Figures 2024
22. July 2024,South African Health Products Regulatory Authority,Guidance,Guideline on Co-applicancy
22. July 2024,"Team Notified Body, Europe",Template,IVD Confirmation Letter Template-V2-20240710
22. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adopted International Scientific Guidelines
22. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adopted International Scientific Guidelines
22. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adopted International Scientific Guidelines
22. July 2024,USA Food & Drug Administration FDA,Guidance,Drugs for the Treatment of Partial Onset Seizures: Adults to Pediatric Patients
22. July 2024,USA Food & Drug Administration FDA,Publication,Designs of clinical swallowability assessments of solid oral dosage forms
22. July 2024,USA Food & Drug Administration FDA,Guidance,Application User Fees for Combination Products
22. July 2024,USA Food & Drug Administration FDA,Guidance,Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment
22. July 2024,USA Food & Drug Administration FDA,Guidance,Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy
22. July 2024,USA Food & Drug Administration FDA,Adenda,Guidance Documents CBER is Planning to Publish During Calendar Year 2024
22. July 2024,USA Food & Drug Administration FDA,Toolkit,Supply Chain Security Toolkit for Medical Products
22. July 2024,USA Food & Drug Administration FDA,Newsletter,Division of Standards and Conformity Assessment
22. July 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations  -Oligonucleotide Therapeutics
22. July 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations  for Radiolabeled Mass Balance Studies
22. July 2024,World Health Organisation WHO,Guidance,"Establishing quality specifications for medicines, vaccines and in vitro diagnostics"
15. July 2024,Egyptian Drug Authority,Guidance,EEC/ 93/42CMDD in case of expiry of quality certificates
15. July 2024,Egyptian Drug Authority,Formulary,Conventional Anticancer Drugs
15. July 2024,European Commission,Guidance,MDCG 2020-16 rev.3 Guidance on Classification Rules for IVDR
15. July 2024,European Commission,Regulation,"Amending EU) 2017/745 & (EU) 2017/746,  gradual roll-out of Eudamed"
15. July 2024,European Commission,Information session,MDR/IVDR for international regulators – 4 July 2024 | IVDR Transition
15. July 2024,European Medicines Agency,Fees,New Fee Regulation (applicable from 1 January 2025)
15. July 2024,European Medicines Agency,Update,2023 annual report of the European Medicines Agency
15. July 2024,European Medicines Agency,Report,Focus group on submission predictability: Final report
15. July 2024,European Medicines Agency,Q&A,Questions and Answers on the 'OPEN' Framework for Non-EU authorities
15. July 2024,European Medicines Agency,Guidance,Procedural advice on paediatric applications
15. July 2024,European Medicines Agency,Guidance,eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD)
15. July 2024,European Medicines Agency,Meeting,Highlights fifth EMA- Association of the European Self Care Industry (AESGP)
15. July 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2024
15. July 2024,European Medicines Agency,Report,2023 SME Annual Report
15. July 2024,European Medicines Agency,Recommendations,Classification of advanced therapy medicinal products
15. July 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report June 2024
15. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure
15. July 2024,Medicines and Healthcare products Regulatory Agency,Blog Post,Navigating the Future: Building the AI and Digital Regulations Service
15. July 2024,Medical Device Authority Malaysia,Timeline,MeDC@St3.0 PROJECT DEVELOPMENT TIMELINE
15. July 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements,Standards Mutations
15. July 2024,SWISSMEDIC,Guidance,Pflichten mit der Durchführung der Instandhaltung von Medizinprodukten
15. July 2024,SWISSMEDIC,Journal,Swissmedic Journal June 2024
15. July 2024,"Team Notified Body, Europe",Guidance,Transfer Agreement for Surveillance of Legacy Devices V2
15. July 2024,"Team Notified Body, Europe",List,Team-NB Position Paper list (update July 2nd 2024)
15. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Authorised Prescriber: online system guidance
15. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Exporting â Ventilator
15. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Transmissible Spongiform Encephalopathies (TSE)
15. July 2024,USA Food & Drug Administration FDA,Guidance,Q&A Misinformation About Medical Devices and Prescription Drugs
15. July 2024,USA Food & Drug Administration FDA,Guidance,Purpose and Content of Use-Related Risk Analyses
15. July 2024,USA Food & Drug Administration FDA,Guidance,Clinical Considerations for Studies of Devices to Treat Opioid Use Disorder
15. July 2024,USA Food & Drug Administration FDA,Guidance Reminder,Prepare to transition to Laser Notice No. 56
15. July 2024,USA Food & Drug Administration FDA,Guidance,"510k Submissions, Dental Composite Resin Devices | Dental Curing Lights"
15. July 2024,USA Food & Drug Administration FDA,SOPP,Processing and Review Management for Investigational New Drug Applications
15. July 2024,World Health Organisation WHO,Guidance,WHO updates laboratory biosecurity guidance | Radiation safety culture Newsletter: WHO pharmaceuticals NEWSLETTER
8. July 2024, ANVISA Brazil,Technical Note,"RDC ANVISA No. 886, of June 26, 2024"
8. July 2024,Egyptian Drug Authority,Consultation,Guideline for Preclinical testing and clinical investigation for Medical devices
8. July 2024,European Commission,Guidance,Update - MDCG 2021-5 Rev.1 - Guidance on standardisation for medical devices
8. July 2024,European Commission,Factsheet,Cross-border Healthcare 2022: Recent data implementation of Dir. 2011/24/EU
8. July 2024,European Medicines Agency,Template,Products Management Services (PMS) - (IDMP) in Europe - Chapter 7
8. July 2024,European Medicines Agency,Paper,ICH - Integrating real-world evidence into regulatory decision-making
8. July 2024,European Directorate for the Quality of Medicines & HealthCare,Report,2023 EDQM annual report published in new engaging digital format
8. July 2024,European Directorate for the Quality of Medicines & HealthCare,News,European Pharmacopoeia Supplement 11.6
8. July 2024,International Medical Device Regulators Forum,Consultation,Good machine learning practice for medical device development
8. July 2024,International Medical Device Regulators Forum,SOP,IMDRF Standard Operating Procedures
8. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies
8. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
8. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Implementation of medical devices future regime
8. July 2024,Medical Device Authority Malaysia,Announcement,Implementation of MDA-CAB Workshop 2024 Outcomes
8. July 2024,SWISSMEDIC,Application,Fee reduction: clinical investigations & performance studies - Medical Devices
8. July 2024,SWISSMEDIC,Guidance,Guidance document Formal requirements
8. July 2024,SWISSMEDIC,Guidance,SwissPAR
8. July 2024,SWISSMEDIC,Forms,New authorisation of human medicinal products
8. July 2024,SWISSMEDIC,Form,Gesuch Verzicht Betriebsbewilligung Arzneimittel (inkl. Blut) / TpP/GT/GVO
8. July 2024,SWISSMEDIC,Form,Order form for a CPP (Certificate of a Pharmaceutical Product)
8. July 2024,SWISSMEDIC,Guidance,Clinical investigations with medical devices
8. July 2024,SWISSMEDIC,Guidance,Performance studies with IVD
8. July 2024,"Team Notified Body, Europe",Template,Transfer Agreement for Surveillance of Legacy Devices
8. July 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Cost Recovery Implementation Statement 2024-2025
8. July 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Certified copies of TGA licences and certificates
8. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulatory changes for software based medical devices
8. July 2024,USA Food & Drug Administration FDA,Report,Modernizing the New Drugs Regulatory Program - Impact Narrative 2023.
8. July 2024,USA Food & Drug Administration FDA,News,CDRH Announces Expansion of the Total Product Life Cycle Advisory Program
8. July 2024,USA Food & Drug Administration FDA,Update,NEW Version 2.9 FDALabel: Full-Text Search of Drug Product Labeling
8. July 2024,USA Food & Drug Administration FDA,Guidance,Recognition of Voluntary Consensus Standards - Pharmaceutical Quality
8. July 2024,USA Food & Drug Administration FDA,Guidance,Pharmacoepidemiological Studies Real-World. Safety Assessment of Medicines
8. July 2024,USA Food & Drug Administration FDA,Standard,Measuring the Size of Nanoparticles in Aqueous Media
1. July 2024,European Commission,Guidance,MDCG 2024-10 - Clinical evaluation of orphan medical devices
1. July 2024,European Commission,Consultation,EU Health Technology Assessment Regulation
1. July 2024,European Commission,Report,Serious Adverse Reactions and Events For Tissues And Cells
1. July 2024,European Medicines Agency,Template,GLP compliance: Non-clinical studies GLP compliance (annex to the cover letter)
1. July 2024,European Medicines Agency,Guidance,ICH M12 on drug interaction studies - Scientific guideline
1. July 2024,European Medicines Agency,Guidance,Pre-authorisation guidance
1. July 2024,European Medicines Agency,Guidance,Transfer of marketing authorisation: questions and answers
1. July 2024,European Medicines Agency,Guidance,Q&A Regulation (EU) 2023/1182 for centrally authorised medicinal products
1. July 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use 24-27 June 2024
1. July 2024,European Medicines Agency,Guidance,Clinical investigation of recombinant & human plasma-derived factor IX products
1. July 2024,European Medicines Agency,Guidance,Clinical Trial Information System (CTIS) - Sponsor handbook
1. July 2024,European Medicines Agency,News,CTIS newsflash - 28 June 2024
1. July 2024,European Medicines Agency,Guidance,Paediatric investigation plan (PIP) - Key elements guidance
1. July 2024,European Directorate for the Quality of Medicines & HealthCare,News,Extractable elements in plastic materials for pharmaceutical use (2.4.35) adopted
1. July 2024,European Directorate for the Quality of Medicines & HealthCare,Report,National requirements for non-prescription medicines & reclassification of medicines
1. July 2024,International Medical Device Regulators Forum,Guidance,In Vitro Diagnostic Medical Device Market Authorization Table of Contents
1. July 2024,International Medical Device Regulators Forum,Guidance,Non-In Vitro Diagnostic Medical Device Market Authorization Table of Contents
1. July 2024,SWISSMEDIC,Form,BW101_10_019e_FO Confirmation electronic submission
1. July 2024,SWISSMEDIC,Template,FSC-Example of a product list
1. July 2024,SWISSMEDIC,Checklist,Inspektion von Systemen der Vigilance betreffend Medizinprodukten
1. July 2024,SWISSMEDIC,Guidance,Authorisation of veterinary medicinal products
1. July 2024,SWISSMEDIC,News,Go-live for the swissdamed Actors module
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device regulation changes
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Prescription lenses: exempt medical devices
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,IVD sponsors: a roadmap to market
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Determinations for Australian conformity assessment bodies
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Sponsor six monthly report - supply of unapproved therapeutic goods
1. July 2024,USA Food & Drug Administration FDA,Notice,Laboratory Developed Tests: Small Entity Compliance Guide
1. July 2024,USA Food & Drug Administration FDA,Standards,"List of Recognized Standards, Recognition List Number: 062"
1. July 2024,USA Food & Drug Administration FDA,Report,New Drugs Regulatory Program Modernization – Impact Narrative Update 2023.
1. July 2024,USA Food & Drug Administration FDA,Guidance,Diversity Action Plans - Underrepresented Populations in Clinical Studies
1. July 2024,USA Food & Drug Administration FDA,Update,eSTAR Program
1. July 2024,USA Food & Drug Administration FDA,Report,Real-World Evidence Submissions CBER and CDER
1. July 2024,USA Food & Drug Administration FDA,Science,Natural Language Processing - Directional Pharmacokinetic Drug-Drug Interactions
1. July 2024,USA Food & Drug Administration FDA,Guidance,Essential Drug Delivery Outputs for Devices Delivering Drugs & Biologics
24. June 2024,Bureau of Indian Standards,Standard,IS 23485 Medical Devices - QMS Requirements & Safety & Performance
24. June 2024,Egyptian Drug Authority,Guidance,Announcement of updates in the General Directorate of Stability
24. June 2024,European Commission,Guidance,Phthalates in certain medical devices
24. June 2024,European Commission,Guidance,"MDCG 2022-13 Rev.1 Designation, re-assessment and notification of CABs"
24. June 2024,European Commission,Regulation,Regulation (EC) 1234/2008 variations to the terms of marketing authorisations
24. June 2024,European Medicines Agency,News,Faster access to clinical trial information in Europe
24. June 2024,European Medicines Agency,Guidance,15. Updates Clinical Trial Information System CTIS
24. June 2024,European Medicines Agency,Guidance,What EMA publishes and when
24. June 2024,"Health Products Regulatory Authority (HPRA) , Ireland",Guidance,Updated questions and answers on the Windsor Framework
24. June 2024,International Council for Harmonisation,Meeting,"ICH Assembly Meeting, Fukuoka, Japan, June 2024"
24. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,20 medical device registration review guidelines
24. June 2024,SWISSMEDIC,Guidance,Simplification of requirements for renewed authorisation of medicinal products
24. June 2024,SWISSMEDIC,Guidance,Requesting product certificates (CPP)
24. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Conformity assessment procedures for immunohematology reagents
24. June 2024,USA Food & Drug Administration FDA,Regulations,Final rule that establishes certification regulations for certain medical gases
24. June 2024,USA Food & Drug Administration FDA,Guidance,Facility Readiness: Goal Date Decisions Under GDUFA
24. June 2024,USA Food & Drug Administration FDA,Update,Recognized Consensus Standards database
24. June 2024,USA Food & Drug Administration FDA,Report,Enhancing Clinical Study Diversity
24. June 2024,USA Food & Drug Administration FDA,Request,input on certain Non-Device Software Functions and Impacts to Patient Safety
24. June 2024,USA Food & Drug Administration FDA,Study,Interpretation of info about Rx drugs in scientific publications vs. promotional pieces
24. June 2024,USA Food & Drug Administration FDA,Guidance,"Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection"
24. June 2024,USA Food & Drug Administration FDA,Guidance,Demonstrating Interchangeability With a Reference Product: Update
24. June 2024,USA Food & Drug Administration FDA,Update,Laboratory Developed Tests
24. June 2024,World Health Organisation WHO,Report,Global Patient Safety Report 2024
17. June 2024,European Commission,Guidance,MDCG 2024-1-5 - Urogynaecological Surgical Mesh Implants (June 2024)
17. June 2024,European Commission,Meeting,MDCG Subgroup on Standards (WG 2)
17. June 2024,European Commission,Guidance,Guidance on outcomes for joint clinical assessments
17. June 2024,European Commission,Guidance,Reporting requirements in joint clinical assessments
17. June 2024,European Medicines Agency,Guidance,Variations categories and procedures: Regulation (EC) No 1234/2008
17. June 2024,European Medicines Agency,Guidance,IRIS guide for applicants
17. June 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee (PRAC) June 2024
17. June 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report
17. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Standards,List of Mandatory Standards for Medical Device Products
17. June 2024,"MEDSAFE, New Zealand",Guidance,Guidelines on the Regulation of Therapeutic Products in New Zealand
17. June 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Software and artificial intelligence (AI) as a medical device
17. June 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Transparency for machine learning-enabled medical devices: guiding principles
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",News,Proactive monitoring of highest-risk medical device clinical trials
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",Checklist,Essential Principles checklist
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Good Manufacturing Practice (GMP) requirements for medicinal products
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Assessed listed medicines evidence guidelines
17. June 2024,USA Food & Drug Administration FDA,Report,Report on the State of Pharmaceutical Quality
17. June 2024,USA Food & Drug Administration FDA,Guidance,Evaluation Methods for Artificial Intelligence (AI)-Enabled Medical Devices
17. June 2024,USA Food & Drug Administration FDA,News,CDER Emerging Drug Safety Technology Program (EDSTP)
17. June 2024,USA Food & Drug Administration FDA,Guidance,Transparency for Machine Learning-Enabled Medical Devices
17. June 2024,USA Food & Drug Administration FDA,Guidance,Bayesian statistical analysis plans to clinical trials demonstration program
17. June 2024,USA Food & Drug Administration FDA,Reminder,Deadline Registration and Listing of Cosmetic Product Facilities and Products
17. June 2024,USA Food & Drug Administration FDA,Guidance,The Limitations of Medical Data in AI
17. June 2024,USA Food & Drug Administration FDA,Guidance,Diabetic Foot Infections: Developing Drugs for Treatment
17. June 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology - Development of Oligonucleotide Therapeutics
10. June 2024,CDSCO India,Guidance,Guidance for Industry on Pharmacovigilance Requirements for Human Vaccines
10. June 2024,Egyptian Drug Authority,Guidance,Pharmaceutical Practices for Diabetes
10. June 2024,Egyptian Drug Authority,Update,Fast Track system for all quality files for locally made products
10. June 2024,European Directorate for the Quality of Medicines & HealthCare,News,Pharmacopoeial Discussion Group achievements
10. June 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 27-30 May 2024
10. June 2024,European Medicines Agency,Newsflash,CTIS newsflash – 31 May 2024
10. June 2024,European Medicines Agency,Guidance,Paediatric investigation plan (PIP) - Key elements guidance
10. June 2024,European Medicines Agency,Guidance,Guidance & Timeline for Simultaneous National Scientific Advice (SNSA)
10. June 2024,ISO (International Organization for Standardization),Standard,"ISO Update May 1, 2024 to June 1, 2024"
10. June 2024,Medical Device Authority Malaysia,Announcement,Implementation of Electronic Establishment License Certificate
10. June 2024,Medical Device Authority Malaysia,Announcement,Implementation of the One-license Policy for Each Establishment Role
10. June 2024,"MEDSAFE, New Zealand",Newsletter,Prescriber Update
10. June 2024,SWISSMEDIC,Guidance,Time limits for authorization applications
10. June 2024,SWISSMEDIC,Form,Drug Master File DMF
10. June 2024,SWISSMEDIC,Guidance,Meeting for applicants held with the Authorisation sector
10. June 2024,SWISSMEDIC,Guidance,Temporary authorisation for human medicinal products
10. June 2024,SWISSMEDIC,Guidance,Variations and extensions HAM
10. June 2024,SWISSMEDIC,Information Sheet,Swissmedic eGov Portal – OCABR standard functions-2023
10. June 2024,SWISSMEDIC,Guidance,Incident economic operators
10. June 2024,SWISSMEDIC,Information Sheet,Archive access
10. June 2024,SWISSMEDIC,Information Sheet,eMessage functions
10. June 2024,SWISSMEDIC,Information Sheet,eIAM Portal Administrator
10. June 2024,SWISSMEDIC,Form,Declaration by the Responsible Person for foreign manufacturers
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Clinical trial notification (CTN) form - user guide
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Good Clinical Practice (GCP) Inspection Program
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Cosmetics or therapeutic goods
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Serious Scarcity Substitution Instruments (SSSIs)
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,112 adopted this International Scientific Guidelines June 2024
10. June 2024,USA Food & Drug Administration FDA,Regulation,To Administratively Destroy Illegal Imported Devices
10. June 2024,USA Food & Drug Administration FDA,Announcement,Participation in three New Collaborative Communities
10. June 2024,USA Food & Drug Administration FDA,Guidance,Processes and Practices Applicable to Bioresearch Monitoring Inspections
10. June 2024,USA Food & Drug Administration FDA,Guidance,Electronic Submission for Marketing Applications Content (BIMO) CBER
10. June 2024,USA Food & Drug Administration FDA,SOPP 8795,Posting and Announcement of PMAs Exemption Approvals and Denials
3. June 2024,CDSCO India,Circular,Testing and evaluation of Medical Devices/ IVDs by Medical Devices Testing Lab.
3. June 2024,Egyptian Drug Authority,Guidance,E-labelling of Medical Leaflets of Medicinal Products for Human Use
3. June 2024,Egyptian Drug Authority,Updates,Fast Track for all files submitted to manage variables for human pharmaceuticals
3. June 2024,European Commission,Dashboard,Study supporting the monitoring of availability of medical devices in the EU
3. June 2024,European Commission,Guidance,MDCG 2022-4 Rev 2 provisions under Article 120 of the MDR legacy devices
3. June 2024,European Commission,Newsletter,MEDICAL DEVICES NEWS Newsletter
3. June 2024,European Commission,Consultation,Health technology assessment – Assessing and Managing Conflicts of Interest
3. June 2024,European Commission,Regulation,(EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed
3. June 2024,European Commission,Regulation,Quality & Safety for Substances of Human Origin for Human Application
3. June 2024,European Medicines Agency,Guidance,"ICH M14 plan, design and analysis of pharmacoepidemiological studies"
3. June 2024,European Medicines Agency,Report,"Annual report highlights progress in science, medicines and health in 2023"
3. June 2024,"Health Sciences Authority (HSA), Singapore",Responses,Amendments to Regulation 23 of the Health Products Regulations
3. June 2024,International Council for Harmonisation,Guidance,ICH M12 Guideline:+ Q&A DRUG INTERACTION STUDIES
3. June 2024,"Health Products Regulatory Authority (HPRA) , Ireland",Guidance,For Health Institutions who manufacture & use In-house IVDs
3. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,48 Guidelines 1 – 24 for the Registration and Review of Medical Devices
3. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,48 Guidelines 25 – 48 for the Registration and Review of Medical Devices
3. June 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure
3. June 2024,South African Health Products Regulatory Authority,Guidance,Patient Information Leaflet for Human Medicines (Categories A D)
3. June 2024,South African Health Products Regulatory Authority,Communication,Summary of Medicine Safety Regulatory Decisions
3. June 2024,South African Health Products Regulatory Authority,Communication,Regulatory Information Management System – Update on Progress
3. June 2024,SWISSMEDIC,Guidance,Performance studies with IVD
3. June 2024,SWISSMEDIC,Guidance,Clinical investigations with medical devices
3. June 2024,SWISSMEDIC,Guidance,Swissmedic eGov Portal – Standard functions CPP
3. June 2024,SWISSMEDIC,Guidance,Clinical Trial Application Dossier
3. June 2024,SWISSMEDIC,Guidance,Guideline Amendments Clinical Trials
3. June 2024,SWISSMEDIC,Checklist,Die Inspektion der Instandhaltung von Medizinprodukten
3. June 2024,SWISSMEDIC,Guidance,Swiss M1 Implementation Guidance
3. June 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Australia’s breast implant risk management framework
3. June 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Cosmetic injectables: import and supply in Australia
3. June 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Action Plan for Medical Devices Progress Report Card: December 2023
3. June 2024,USA Food & Drug Administration FDA,Guidance,Safety of Residues of Veterinary Drugs in Human Food
3. June 2024,USA Food & Drug Administration FDA,Guidance,Platform Technology Designation Program for Drug Development
3. June 2024,USA Food & Drug Administration FDA,Update,Drugs@FDA Data Files
27. May 2024,Egyptian Drug Authority,Guidance,Antimicrobial Use in Infections with Multi-Drug Resistant Organisms (MDROs)
27. May 2024,European Directorate for the Quality of Medicines & HealthCare (EDQM),Guidance,Draft guideline on ‘Content of the dossier for sterile substances’
27. May 2024,European Commission,Report,Study on the implementation of Article 17 of Regulation (EU) 2017/745
27. May 2024,European Commission,Communication,European Health Union: acting together for people's health
27. May 2024,European Medicines Agency,Guidance,Medical devices: new guidance for industry and notified bodies
27. May 2024,European Medicines Agency,Newsflash,CTIS newsflash
27. May 2024,European Medicines Agency,Guidance,IDMP: Chapter 7: XEVMPD and SIAMED II to PMS – Initial migration guide
27. May 2024,European Medicines Agency,Guidance,IRIS guide for applicants
27. May 2024,European Medicines Agency,Guidance,Support for industry on clinical data publication; Anonymisation
27. May 2024,European Medicines Agency,Q&A,Regulatory Procedure Management for the Product Lifecycle Management
27. May 2024,International Medical Device Regulators Forum,Template,8 Slide Template for IMDRF Membership Application Presentations
27. May 2024,Medical Device Authority Malaysia,Registration,Re-Registration Medical Device Applications in the Medc@st 2.0+ System
27. May 2024,Medical Device Authority Malaysia,Consultation,Draft Guidance Document Change Notification for Registered Medical Device
27. May 2024,Department of Health and Social Care UK,Policy Paper,Explanatory Memo on EU regulations 2017/745 & 2017/746 (COM(2024)43)
27. May 2024,Medicines and Healthcare products Regulatory Agency,Standard,Implementation of the future regulations
27. May 2024,Medicines and Healthcare products Regulatory Agency,Standard,Statement of policy intent: international recognition of medical devices
27. May 2024,Medicines and Healthcare products Regulatory Agency,Consultation,Common specification requirements for in vitro diagnostic devices
27. May 2024,South African Health Products Regulatory Authority,Guidance,Reliance - General ECTD & human medicines
27. May 2024,South African Health Products Regulatory Authority,Guidance,Resubmission Of Shipment Documentation For SAHPRA Review and Stamp
27. May 2024,South African Health Products Regulatory Authority,Guidance,"12 Documents, Medical Device Registration Voluntary Feasibility Study"
27. May 2024,Team AB,News,MHRA’s International Recognition Policy for Medical Device Regulations
27. May 2024,Team NB,Survey,Team-NB 2023 Annual Sector Survey & Press Release
27. May 2024,USA Food & Drug Administration FDA,Reclassification,Ophthalmic Devices; Ultrasound Cyclodestructive Device
27. May 2024,USA Food & Drug Administration FDA,Update,ASCA-Accredited Testing Laboratories
27. May 2024,USA Food & Drug Administration FDA,Report,FY 2023 GDUFA Science and Research Report
27. May 2024,USA Food & Drug Administration FDA,SOP,Resolution of Internal Differences of Opinion in Regulatory Decision-Making
27. May 2024,World Health Organisation WHO,Guidance,Data requirements & protocol for efficacy of vector control products
27. May 2024,World Health Organisation WHO,List,"WHO bacterial priority pathogens list, 2024"
20. May 2024,CDSCO India,Notice,Adverse Events reported under Materiovigilance Programme of India
20. May 2024,CDSCO India,Circular,Transition Class C & D Medical Devices under Licensing regime w.e.f 01.10.2023
20. May 2024,European Commission,Update,49 EU MDR and 12 EU IVDR Notified Bodies
20. May 2024,European Commission,Report,"Combine clinical trials of medicinal products, medical devices and IVDs"
20. May 2024,European Commission,Templates,"MDCG 2024-6, 7, 8 and 9 - Preliminary (re-)assessment review templates"
20. May 2024,European Commission,EUDAMED,The new version of EUDAMED 2.14.1 has been deployed.
20. May 2024,European Commission,Survey,Notified bodies survey on certifications and applications
20. May 2024,European Medicines Agency,Guidance,Implementation of ISO standards IDMP
20. May 2024,European Medicines Agency,IDMP,Implementation of ISO standards IDMP Chapter 1 Registration Requirements
20. May 2024,European Medicines Agency,Guidance,EudraVigilance registration documents
20. May 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2024
20. May 2024,Department of Health The Government of the Hong Kong,MDACS,Overview of the Medical Device Administrative Control System (GN-01)
20. May 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Registration & Review of Prefilled Catheter Irrigators (Draft for Comments)
20. May 2024,ISO (International Organization for Standardization),Standard,"ISO Update April 1, 2024 to May 1, 2024"
20. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Good manufacturing practice and good distribution practice
20. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK
20. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices regulations: compliance and enforcement
20. May 2024,SWISSMEDIC,Guidance,Guidance document for requesting product certificates (CPP)
20. May 2024,SWISSMEDIC,Checklist,Inspektion von Aufbereitungseinheiten für Medizinprodukte (AEMP)
20. May 2024,SWISSMEDIC,Reglement,Reglement Schweizerische Pharmakopöegremien
20. May 2024,SWISSMEDIC,Information Sheet,Quick instruction for use of the FO_submission form
20. May 2024,SWISSMEDIC,Guidance,Guidance on the Submission Process for Clinical Trials with Medicinal Products
20. May 2024,SWISSMEDIC,Guidance,Temporary Authorisation to use an unauthorised medicinal product
20. May 2024,SWISSMEDIC,Directory,List Countries with recognised GMP control systems
20. May 2024,SWISSMEDIC,Form,Einfuhr von immunologischen Arzneimittelnoder oder von Blut und Blutprodukten
20. May 2024,SWISSMEDIC,Information Sheet,"import licence for immunological medicinal products, or blood products"
20. May 2024,SWISSMEDIC,Guidance,Change name or domicile of the authorisation holder
20. May 2024,SWISSMEDIC,Guidance,Information sheet Requirements ZL TrP/GT/GMO
20. May 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Notification of a change in sponsorship
20. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Good Clinical Practice (GCP) Inspection Program
20. May 2024,USA Food & Drug Administration FDA,Catalog,Regulatory Science Tools Catalog
20. May 2024,USA Food & Drug Administration FDA,List,Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices
20. May 2024,USA Food & Drug Administration FDA,Report,2023 Drug Trials Snapshots Summary Report
20. May 2024,USA Food & Drug Administration FDA,MDDT Tools,IntraOcular Lens Implant Symptoms (AIOLIS) Instrument.
13. May 2024,Egyptian Drug Authority,Consultation,Draft regulatory guide for the examination of human use products files
13. May 2024,Egyptian Drug Authority,Extension,Exceptional period for entering cosmetic notification on the e-platform
13. May 2024,European Commission,Update,48 EU MDR and 12 EU IVDR Notified Bodies
13. May 2024,European Medicines Agency,Form,"(CTIS) structured data form - substantial, non-substantial modification"
13. May 2024,European Medicines Agency,Recommendation,(PRAC recommendations on signals adopted 8-11 April 2024 Framework for Action: Cross-agency One Health task force framework for action
13. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Software and artificial intelligence (AI) as a medical device
13. May 2024,Medicines and Healthcare products Regulatory Agency,Collection,AI Airlock: the regulatory sandbox for AIaMD
13. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Send and receive information on adverse drug reactions (ADRs)
13. May 2024,Medical Device Authority Malaysia,Circular Letter,Medical Devices Subject to Trade Restrictions
13. May 2024,"Health Sciences Authority (HSA), Singapore",Memorandum,HSA signs memorandum of understanding with Malaysia
13. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulation of software based medical devices
13. May 2024,USA Food & Drug Administration FDA,Guidance,REMS Logic Model: A Framework to Link Program Design With AssessmentGuidance: Remanufacturing of Medical Devices
13. May 2024,USA Food & Drug Administration FDA,Request for Comment,Clinical Research Terms - Innovative Clinical Trial Design
13. May 2024,USA Food & Drug Administration FDA,Record,eSubmitter Application History
13. May 2024,USA Food & Drug Administration FDA,Initiative,General Framework for Adopting LLMs in Regulatory Application
13. May 2024,USA Food & Drug Administration FDA,Annual Summary,Biological Product and HCT/P Deviation Reports
13. May 2024,World Health Organisation WHO,Guidance,Prevention of infections from intravascular peripheral catheters
6. May 2024,Egyptian Drug Authority,Guidance,Naming of Human Pharmaceutical Products
6. May 2024,European Medicines Agency,Guidance,ICH Q3C (R9) Guideline on impurities guideline for residual solvents - Step 5
6. May 2024,European Medicines Agency,Guidance,Quality of medicines questions and answers: Part 1
6. May 2024,European Medicines Agency,Guidance,Defining the Scope of an NIRS Procedure
6. May 2024,European Medicines Agency,Guidance,Appendix 1: Acceptable intakes established for N-nitrosamines
6. May 2024,European Medicines Agency,Concept Paper,Risk Assessment Human Medicinal Products Reproduction and Lactation
6. May 2024,European Medicines Agency,Template,Template for scientific document (parts B-F)
6. May 2024,European Medicines Agency,Report,SME office annual report
6. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Send and receive information on adverse drug reactions (ADRs)
6. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies
6. May 2024,Medicines and Healthcare products Regulatory Agency,Policy Paper,Impact of AI on the regulation of medical products
6. May 2024,Medicines and Healthcare products Regulatory Agency,News,MHRA’s AI regulatory strategy ensures patient safety & industry innovation into 2030
6. May 2024," Health Sciences Authority (HSA), Singapore",Guidance,NEX2US Newsletter Issue 10 | April 2024
6. May 2024, International Medical Device Regulators Forum,Guidance,Assessment & Decision Process for Recognition of CAB Regulatory Reviews
6. May 2024, International Medical Device Regulators Forum,Guidance,Competence and Training Requirements for CABs Conducting Reviews
6. May 2024, International Medical Device Regulators Forum,Guidance,Regulatory Authority Assessment Method for CAB Review
6. May 2024, International Medical Device Regulators Forum,Guidance,Requirements for Regulatory Authority Recognition of CABs Conducting Reviews
6. May 2024, International Medical Device Regulators Forum,Guidance,Principles of Labelling for Medical Devices and IVD Medical Devices
6. May 2024, International Medical Device Regulators Forum,Guidance,Essential Principles of Safety and Performance of Medical Devices and IVDs
6. May 2024, International Medical Device Regulators Forum,Guidance,"Competence, Training, and Conduct Requirements for Reg.  Reviewers"
6. May 2024, International Medical Device Regulators Forum,Guidance,Regulatory Review Report: Guidance Regarding Information to be Included
6. May 2024, International Medical Device Regulators Forum,Whitepaper,IMDRF 25th Session Workshop: White Paper on Reliance
6. May 2024,SWISSMEDIC,Guidance,Parallel Import of a human medicinal product according to Art. 14 para. 2 and 3
6. May 2024,SWISSMEDIC,Guidance,Guidance document for requesting product certificates (CPP)
6. May 2024,SWISSMEDIC,Form,Meldung einer vermuteten unerwünschten Arzneimittelwirkung (UAW)
6. May 2024,"Therapeutic Goods Administration (TGA), Australia",Checklist,Essential Principles checklist
6. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulatory requirements for in-house IVDs
6. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Boundary and combination products and their product category
6. May 2024,USA Food & Drug Administration FDA,Guidance,Enforcement Policy for Certain IVDs
6. May 2024,USA Food & Drug Administration FDA,Guidance,Enforcement Policies Tests During a Section 564 Declared Emergency
6. May 2024,USA Food & Drug Administration FDA,Guidance,Use of a Standard for Uniform Blood & Blood Component Container Labels
6. May 2024,USA Food & Drug Administration FDA,Guidance,"Derived Materials in the Manufacture of Cell, Gene Therapy &Tissue-Engineered"
6. May 2024,USA Food & Drug Administration FDA,Guidance,Safety Testing of Human Allogeneic Cells for Use in Cell-Based Medical Products
6. May 2024,USA Food & Drug Administration FDA,Report,2023 Office of New Drugs (OND) Annual Report
6. May 2024,USA Food & Drug Administration FDA,Report,2023 Office of Translational Sciences Annual Report
6. May 2024,USA Food & Drug Administration FDA,Newsletter,What’s New in Regulatory Science CDER
6. May 2024,USA Food & Drug Administration FDA,News,Helping to Ensure the Safety and Effectiveness of Laboratory Developed Tests
6. May 2024,USA Food & Drug Administration FDA,MDDT Tools,Apple Atrial Fibrillation History Feature
29. April 2024,Drug Regulatory Authority of Pakistan,Guidance,Post Registration Variation  for pharmaceutical and biologic products
29. April 2024,Egyptian Drug Authority,Guidance,Papers to submit to General Department of Evaluation and Control
29. April 2024,European Commission,Update,46 EU MDR and 12 EU IVDR Notified Bodies
29. April 2024,European Commission,Approved,"Gradual roll-out of Eudamed, improve transition of IVD"
29. April 2024,European Medicines Agency,Guidance,Strengthening supply chains of critical medicines
29. April 2024,European Medicines Agency,Report,EMA’s biennial report on stakeholder engagement activities
29. April 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024
29. April 2024,East Africa Regulatory Affairs Association (EARAPA),REOI,Regulatory Process for Certification or Listing of Priority IVDs
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: apply for a variation to your marketing authorisation
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
29. April 2024,Department of Health The Government of the Hong Kong,MDACS,Update-Listed Rapid Antigen Tests for COVID-19 under MDACS
29. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Technical review of the laparoscopic surgical system
29. April 2024,"SEGOB Secretariat of the Interior or the Secretariat for Governance, Mexico",Standard,"PROY-NOM-137-SSA1-2024, Labeling of medical devices."
29. April 2024,SWISSMEDIC,Form,Gesuch Betriebsbewilligung - Basisformular Arzneimittel (inkl. Blut)
29. April 2024,SWISSMEDIC,Form,Gesuch Betriebsbewilligung - Zusatzblatt Arzneimittel (inkl. Blut)
29. April 2024,SWISSMEDIC,Form,Gesuch Betriebsbewilligung - Basisformular TpP/GT/GVO
29. April 2024,SWISSMEDIC,Form,Gesuch Betriebsbewilligung - Zusatzblatt TpP/GT/GVO
29. April 2024,SWISSMEDIC,Guidance,Application establishment licence - medicinal products TP/GT/GMO
29. April 2024,SWISSMEDIC,Guidance,Authorisation of human medicinal product - known active substance
29. April 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Established acceptable intake for nitrosamines in medicines
29. April 2024,USA Food & Drug Administration FDA,Report,Postmarketing Requirements and Commitments: Reports
29. April 2024,USA Food & Drug Administration FDA,Record,eSubmitter Application History
29. April 2024,USA Food & Drug Administration FDA,Announcement,Home as a Health Care Hub
29. April 2024,USA Food & Drug Administration FDA,Guidance Snapshots,E19 A Selective Approach to Safety Data Collection
29. April 2024,USA Food & Drug Administration FDA,Guidance,Promotional Labeling and Advertising Considerations Biologics Q&A
29. April 2024,USA Food & Drug Administration FDA,Guidance,Content Format of Composition Statement of Ingredients Labeling NDAs ANDAs
29. April 2024,USA Food & Drug Administration FDA,Guidance x 3,Cancer Clinical Trial Eligibility Criteria
29. April 2024,USA White House Office for Information and Regulatory Affairs,Conclusion,Regulatory Review Medical Devices; Laboratory Developed Tests
29. April 2024,World Health Organisation WHO,Guidance,The selection and use of essential medicines (2023) - TRS 1049
22. April 2024,Egyptian Drug Authority,Form,Updating The Registeration Form
22. April 2024,European Directorate for the Quality of Medicines & HealthCare,Deadline,Survey on strategy for Ph. Eur. quality standards for MABs
22. April 2024,European Directorate for the Quality of Medicines & HealthCare,Consultation,Guidance Traceability of Medicines in Hospital Settings
22. April 2024,European Commission Medical Device Coordination Group,Guidance,MDCG 2024-4 Safety reporting in performance studies of EU IVDR Template: MDCG 2022-9 / Rev.1 Summary of safety and performance
22. April 2024,European Commission Medical Device Coordination Group,Guidance,MDCG 2024-5 - Guidance on the Investigator’s Brochure content
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,RegulatoryConnect
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Rolling review for marketing authorisation applications
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,150-day assessment for national applications for medicines
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,MAH submission of Nitrosamine risk and confirmatory testing
22. April 2024, Medical Device Authority Malaysia,Announcement,Quotation Medical Device Testing Services
22. April 2024, Medical Device Authority Malaysia,Directive,Implementation of One License Policy For Each Establisment Role
22. April 2024,Department of Health The Government of the Hong Kong,MDACS,Update-Medical Device Information System
22. April 2024,SWISSMEDIC,Guidance,Medical Device Software
22. April 2024,SWISSMEDIC,Form,New authorisation of human medicinal products
22. April 2024,SWISSMEDIC,Guidance,GMP compliance by foreign manufacturers
22. April 2024,SWISSMEDIC,Form,Status of authorisation applications abroad
22. April 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Availability of Instructions For Use (IFU) in more flexible formats
22. April 2024,"Therapeutic Goods Administration (TGA), Australia",Standard,Sunscreen Standard update
22. April 2024,USA Food & Drug Administration FDA,Announcement,New Dataset - Chemical Characterization Methods for Biocompatibility
22. April 2024,USA Food & Drug Administration FDA,Announcement,CDER Center for Clinical Trial Innovation (C3TI)
22. April 2024,USA Food & Drug Administration FDA,SOPP 8101.2,Scheduling and Documentation of Meetings with Industry
22. April 2024,USA Food & Drug Administration FDA,Guidance,Data Standards Catalog
22. April 2024,USA Food & Drug Administration FDA,Reports,CDRH Issues 2024 Safety and Innovation Reports
22. April 2024,USA Food & Drug Administration FDA,Guidance Snapshots,Pharmacokinetics Impaired Renal Function
22. April 2024,USA Food & Drug Administration FDA,CDER Discussion,Proposed Rule to Help Patients Understand Their Prescription Medication Information
22. April 2024,World Health Organisation WHO,Guidance,"WHO pharmaceuticals newsletter - No. 2, 2024"
15. April 2024,ANVISA Brazil,Normative Instruction,Procedure for acceptance of applications - Mutual Recognition
15. April 2024,CDSCO India,Guidance,Stabilty Studies of In-vitro Diagnostic Medical Device (IVDMD)
15. April 2024,Egyptian Drug Authority,Guidance,Mechanism of inquiry and follow-up of the position of stability studies
15. April 2024,European Directorate for the Quality of Medicines & HealthCare (EDQM),Press Release,JP and Ph. Eur. launch harmonisation project for API & Finished Form
15. April 2024,European Commission,Final Report,Study on the implementation of Article 17 of EU MDR in EU
15. April 2024,European Commission,Dashboard,A Study & Dashboard reprocessing and reuse of single-use-devices
15. April 2024, European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee 8-11 April 2024
15. April 2024,ISO (International Organization for Standardization),Standard,"ISO Update March 1, 2024 to April 1, 2024"
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Borderlines with medical devices and other products in Great Britain
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: apply for a parallel import licence
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical trials for medicines: apply for authorisation in the UK
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product
15. April 2024,Medicines and Healthcare products Regulatory Agency,Pharmacopoeia Guidance,ATMP T Cell and NK Cell Characterisation Assays
15. April 2024,Department of Health and Social Care,Guidance,Medical technology innovation classification framework
15. April 2024,Department of Health and Social Care,Policy Paper,Medical technology strategy
15. April 2024,"MEDSAFE, New Zealand",Consultation,Outcome of the consultation on standards for contraceptive devices
15. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Clinical Evaluation and Registration Review of Absorbable Sutures
15. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Registration & Review of Matrix Soft Tissue Wound Repair
15. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Notice,Medical Device Registration Review Guideline Plan (No. 17 [2024])
15. April 2024,Saudi Food & Drug Authority,Guidance,General Considerations for Preclinical Studies Submissions
15. April 2024,SWISSMEDIC,Form,Adverse Reaction Report CT ATMP
15. April 2024,SWISSMEDIC,Information Sheet,"Reporting Adverse reactions with ATMPs,(bacteriophages, etc.)"
15. April 2024,SWISSMEDIC,Technical interpretation,Retention Samples
15. April 2024,SWISSMEDIC,Form,Reporting a suspected adverse drug reaction (UAW)
15. April 2024,SWISSMEDIC,Checklist,Application for operating license to handle controlled substances
15. April 2024,SWISSMEDIC,Regulation,Regulations on fee collection
15. April 2024,SWISSMEDIC,Form,Field Safety Corrective Action (FSCA) Report
15. April 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Clinical trial notification (CTN) form
15. April 2024,USA Food & Drug Administration FDA,Record,eSubmitter Application History
8. April 2024, CDSCO India,Notice,Strengthening of Private Medical Device Testing Laboratory
8. April 2024,Egyptian Drug Authority,Guidance,Third edition regulatory guide for the decision of the EDA  No. (450) of 2023
8. April 2024,Egyptian Drug Authority,Guidance,Rational use of antifungals
8. April 2024,European Medicines Agency,Procedure,Procedural Advice on Zero day MR procedure
8. April 2024,European Medicines Agency,Q&A,Pharmacovigilance Legislation
8. April 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Regulatory Updates for Therapeutic Product Registration
8. April 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Points to Consider for Singapore Labelling
8. April 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Implementation of electronic labelling (e-labelling) Non Pres. GS
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,"Assistive technology: definitions, examples and safe use"
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,ICH Technical Requirements for Pharmaceuticals for Human Use Guidelines
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Drugs and pharmaceutical electronic market information tool (eMIT)
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,UK Parallel Import Licences Following Agreement of the Windsor Framework
8. April 2024,Medicines and Healthcare products Regulatory Agency,Blog,DSUR Submissions and Fees are Changing from 1 June 2024
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing & Access Pathway & Target Product Profile Toolkit
8. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Notice on the public solicitation: industry standards for clinical evaluation
8. April 2024,Department of Health The Government of the Hong Kong,MDACS,Medical Device Information System
8. April 2024,SWISSMEDIC,Guidance,Export Certificates
8. April 2024,SWISSMEDIC,Strategisches Dokument,Verhaltenskodex Swissmedic
8. April 2024,SWISSMEDIC,Journal,Swissmedic Journal March 2024
8. April 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Updated guidelines for Assessed listed medicines
8. April 2024,USA Food & Drug Administration FDA,eSTAR,eSTAR is now available for voluntary use for 513(g)
8. April 2024,USA Food & Drug Administration FDA,Guidance,FDA Regional Implementation Guide for E2B(R3) Electronic Transmission of Individual Case Safety Reports for Drug and Biological Products
8. April 2024,USA Food & Drug Administration FDA,Guidance,Providing Regulatory Submissions in Electronic Format: IND Safety Reports
8. April 2024,USA Food & Drug Administration FDA,Guidance,E-Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies
8. April 2024,USA Food & Drug Administration FDA,Guidance,Data Integrity for In Vivo Bioavailability and Bioequivalence Studies
8. April 2024,USA Food & Drug Administration FDA,Report,The Office of Pharmaceutical Quality (OPQ) Issues Annual Report for 2023
8. April 2024,USA Food & Drug Administration FDA,"Snapshot, Podcast, Guidance",Considerations for Antibody-Drug Conjugates
8. April 2024,USA Food & Drug Administration FDA,Guidance MDDT,Lethal Arrhythmia Database Qualified as an MDDT
8. April 2024,USA Food & Drug Administration FDA,Report,CDER’s Office of Communications (OCOMM) Annual Report for 2023
8. April 2024,Medicines Control Authority of Zimbabwe (MCAZ),Invitation,new system of processing applications for registration - Circular 26 of 2023
8. April 2024,World Health Organisation WHO,Guidance,Implementation guide to the routine health information system toolkit
1. April 2024, Drug Regulatory Authority of Pakistan,Guidance,Good Clinical Practice (GCP) Inspections
1. April 2024, Egyptian Drug Authority,Declaration,Registration of pharmaceutical form medical supplies (Dosage form)
1. April 2024, European Commission,Guidance,Responsible use of generative Artificial Intelligence in research
1. April 2024, European Commission,Request,Use of brain stimulators not having an intended medical purpose
1. April 2024, European Commission,Overview,Devices subject to the clinical evaluation consultation procedure
1. April 2024, European Commission,Guidance,Quantitative Evidence Synthesis: Direct and Indirect Comparisons
1. April 2024, European Commission,Guidance,Overview of language requirements for manufacturers of medical devices
1. April 2024, European Medicines Agency,Guidance,"Quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials"
1. April 2024, European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure
1. April 2024, European Medicines Agency,Guidance,"Preparation, conduct and reporting of EU pharmacovigilance inspections"
1. April 2024, European Medicines Agency,Fees,Regulatory information – adjusted fees for applications to EMA from 1 April 2024
1. April 2024,International Medical Device Regulators Forum,Outcome Statement,25th Session of the IMDRF 11-15 March 2024
1. April 2024,International Medical Device Regulators Forum,Jurisdictional Updates,25th Session of the IMDRF Regulatory Updates
1. April 2024,International Medical Device Regulators Forum,Working Group Updates,25th Session of the IMDRF Working Groups
1. April 2024,International Medical Device Regulators Forum,Industry Workshops,25th Session of the IMDRF Industry Workshop “Reliance”
1. April 2024, Medical Device Authority Malaysia,Announcement,Faster Approval For Establishment License Application
1. April 2024, Medical Device Authority Malaysia,Guidance,Establishment License Application
1. April 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Regulation of devices in Northern Ireland
1. April 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Apply for manufacturer or wholesaler of medicines licences
1. April 2024, Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage authorisation, report safety issues"
1. April 2024, Medicines and Healthcare products Regulatory Agency,Guidance,RegulatoryConnect
1. April 2024, Medicines and Healthcare products Regulatory Agency,Report,SaBTO annual report 2022 to 2023
1. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,For the review of medical device usability engineering registration
1. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,For the registration review of high-frequency surgical devices
1. April 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Uniform recall procedure for therapeutic goods (URPTG)
1. April 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Authorised Prescriber Scheme
1. April 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Supporting documentation for inclusion of a medical device
1. April 2024, USA Food & Drug Administration FDA,SOPP,Managing MDUFA User Fee Payments and Billing
1. April 2024, USA Food & Drug Administration FDA,Annual Report,National Center For Toxicological Research
1. April 2024, USA Food & Drug Administration FDA,Guidance,Handling & Retention of Bioavailability BA & Bioequivalence BE Testing Samples
1. April 2024, USA Food & Drug Administration FDA,Guidance,Animal Studies for Dental Bone Grafting - Premarket Notification (510(k))
1. April 2024, World Health Organisation WHO,Technical brief,Artificial intelligence in sexual and reproductive health and rights
1. April 2024, World Health Organisation WHO,Publication,Benefits & risks of using  AI for pharmaceutical development & delivery
25. March 2024, CDSCO India,Circular,PSUR of Medical devices / IVD through Medical Devices Portal
25. March 2024, European Commission,Press Release,Political agreement on European Health Data Space
25. March 2024, European Commission,Press Release,EU AI Act: first regulation on artificial intelligence
25. March 2024, European Commission,Posters,Prevention of non-communicable diseases
25. March 2024, European Commission,Report,Prevention of non-communicable diseases
25. March 2024, European Commission,Guidance,Deliverables of MDCG Subgroups – March 2024
25. March 2024, European Commission,Consultation,Benefit-risk assessment of phthalates in certain medical devices
25. March 2024, European Medicines Agency,Guidance,Electronic submission of information on investigational products
25. March 2024, European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) March 2024
25. March 2024, International Electrotechnical Commission,Standard,IEC 80601-2-78:2019+AMD1:2024 medical robots for…
25. March 2024, International Electrotechnical Commission,Standard,IEC 63412-1:2024 PRV Ultrasonics - Shear-wave elastography
25. March 2024, International Electrotechnical Commission,Standard,IEC 80601-2-58:2024 lens removal and vitrectomy devices
25. March 2024, International Electrotechnical Commission,Standard,IEC 61674:2024 Dosimeters X-ray diagnostic imaging
25. March 2024, South African Health Products Regulatory Authority,News,South African eCTD 3.0 Launch
25. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product
25. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Advanced therapy medicinal products: regulation and licensing
25. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Export drugs and medicines: special rules
25. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
25. March 2024," MEDSAFE, New Zealand",Consultation,Proposed updates to Pharmacovigilance Guidance
25. March 2024, Italian Medicines Agency,Guidance,Ancillary medicinal substances incorporated in medical device
25. March 2024, Swissmedic,Guidance,Application for license to grow cannabis for medical purposes
25. March 2024," Therapeutic Goods Administration (TGA), Australia",Consultation,Companion diagnostics guidance update
25. March 2024, USA Food & Drug Administration FDA,Guidance,Controlled Correspondence Related to Generic Drug Development
25. March 2024, USA Food & Drug Administration FDA,Guidance,"Manufacture of Batches in Support of NADAs, ANADAs, & CNADAs"
25. March 2024, USA Food & Drug Administration FDA,Guidance,Pharmacokinetics in Patients with Impaired Renal Function
25. March 2024, USA Food & Drug Administration FDA,Guidance,Real-World Evidence: Non-Interventional Studies Drug & Biologics
25. March 2024, USA Food & Drug Administration FDA,Update,Breakthrough Devices Program Metrics & Marketing Authorizations List
25. March 2024, USA Food & Drug Administration FDA,Proposed Rule,Drug Products with Demonstrable Difficulties for Compounding
25. March 2024, USA Food & Drug Administration FDA,Report,Division of Applied Regulatory Science Annual Report 2023
25. March 2024, USA Food & Drug Administration FDA,Paper,Harnessing the Potential of Artificial Intelligence
18. March 2024, ANVISA Brazil,Notice,Updates safety and performance requirements for medical devices
18. March 2024, European Commission,Proposal,Better lifecycle management of medicine authorisation
18. March 2024, European Commission,Guidance,MDCG 2024-3 - Clinical Investigation Plan for medical devices
18. March 2024, European Commission,Survey,Notified Bodies Survey on certifications and applications (MDR/IVDR) Report:Member State Coordination Group on HTA (8 March 2024)
18. March 2024, European Commission,Factsheet,Steering innovation to address unmet medical needs
18. March 2024, European Commission,Factsheet,Access to medicines in all Member States
18. March 2024, European Medicines Agency,Guidance,Pharmacovigilance Risk Assessment Committee 4-7 March 2024
18. March 2024, European Medicines Agency,Guidance,EudraVigilance support guide
18. March 2024, European Medicines Agency,Guidance,Procedural advice for orphan medicinal product
18. March 2024, European Medicines Agency,Guidance,Innovation Task Force (ITF) briefing meetings
18. March 2024, International Medical Device Regulators Forum,Guidance,Adverse Event Terminology
18. March 2024, Medicines and Healthcare products Regulatory Agency,Report,Equity in Medical Devices:Independent Review
18. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Established Medicines marketing authorisation application changes
18. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
18. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,British Pharmacopoeia Environmental sustainability
18. March 2024, East Africa Regulatory Affairs Association (EARAPA),Announcement,PPB Kenya becomes Affilate member of MDSAP Program.
18. March 2024, Swissmedic,Form,Quality defect report
18. March 2024, Swissmedic,Guidance,Guidance Industry eCTD
18. March 2024, Swissmedic,Guidance,Members list of Veterinary Medicines Expert Committees (VMEC)
18. March 2024," Therapeutic Goods Administration (TGA), Australia",Notice,Referring to cosmetic injectables in advertising
18. March 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Clinical trial notification (CTN) form - user guide
18. March 2024, USA Food & Drug Administration FDA,Guidance,"Early Alzheimer’s Disease: Developing Drugs for Treatment,"
18. March 2024, USA Food & Drug Administration FDA,Guidance,Select Updates for the Premarket Cybersecurity Guidance
18. March 2024, USA Food & Drug Administration FDA,Guidance,"Reportable Labeling Changes for NDA, ANDA Nonprescription Drugs"
18. March 2024, USA Food & Drug Administration FDA,Guidance,Evaluation of Thermal Effects of Medical Devices
18. March 2024, USA Food & Drug Administration FDA,Guidance,E2D(R1) Post-Approval Safety Data
18. March 2024, USA Food & Drug Administration FDA,Guidance,The Q-Submission Program
18. March 2024, USA Food & Drug Administration FDA,Proposed Rule,Labeling Requirements for New Animal Drugs
18. March 2024, World Health Organisation WHO,Mobile App,Biosafety risk assessment
11. March 2024, Egyptian Drug Authority,Declaration,Extension to complete the scientific files of veterinary preparations
11. March 2024, European Commission,Consultation,EU Health Technology Assessment Regulation
11. March 2024, European Commission,Guidance,Advice on the indirect antiglobulin tests on request from the MDCG
11. March 2024, European Commission,Update,44 Notified Bodies EU MDR 2017/746 medical devices
11. March 2024, European Commission,Update,12 Notified Bodies EU IVDR 2017/746 in vitro diagnostics
11. March 2024, European Commission,Regulation,Harmonised standards for terminal sterilisation and packaging
11. March 2024, European Medicines Agency,Guidance,Excipients in the labelling and package leaflet of medicinal products
11. March 2024," Health Products Regulatory Authority (HPRA) , Ireland",Newsletter,HPRA Medical Devices 29 February 2024
11. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,"Medicines: packaging, labelling and patient information leaflets"
11. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Established Medicines marketing authorisation application changes
11. March 2024," Health Sciences Authority (HSA), Singapore",Guidance,13 Guidance documents for medical devices - March 2024
11. March 2024, ISO (International Organization for Standardization),Standard,"ISO Update February 1, 2024 to March 1, 2024"
11. March 2024, Swissmedic,Report,Authorisations of complementary & herbal medicinal products in 2023
11. March 2024, Swissmedic,Journal,Swissmedic Journal 02/2024
11. March 2024, Swissmedic,Consultation,ICH Guideline E2D(R1) launched in Switzerland
11. March 2024, Swissmedic,Guidance,Guidance document Time limits for authorization applications
11. March 2024, Swissmedic,Guidance,Members list of Human Medicines Expert Committees (HMEC)
11. March 2024," Therapeutic Goods Administration (TGA), Australia",Notice,Health Canada agreement on GMP inspections initiative
11. March 2024," Therapeutic Goods Administration (TGA), Australia",Notice,"Update to manufacturing principles for medicines, API & Sunscreens"
11. March 2024," Therapeutic Goods Administration (TGA), Australia",Publication,PIC/S Guide to GMP for medicinal products – version 16
11. March 2024," Therapeutic Goods Administration (TGA), Australia",Publication,Establishment of the Medicines Repurposing Program
11. March 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Changes to the Permissible Ingredients Determination
11. March 2024," Therapeutic Goods Administration (TGA), Australia",Update,Update to listed medicine ingredients in March 2024
11. March 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising health services
11. March 2024, USA Food & Drug Administration FDA,Guidance,"Understanding in Informed Consent Guidance for Sponsors,"
11. March 2024, USA Food & Drug Administration FDA,Guidance,Q14 Analytical Procedure Development
11. March 2024, USA Food & Drug Administration FDA,Guidance,Q2(R2) Validation of Analytical Procedures
11. March 2024, USA Food & Drug Administration FDA,Guidance,Augmented Reality and Virtual Reality Medical Devices
11. March 2024, World Health Organisation WHO,Policy Brief,Medication without harm
4. March 2024, ANVISA Brazil,Technical Note,The use of smartwatches for blood glucose measurement
4. March 2024, CDSCO India,Guidance,Applications of PSURs MA of New Drugs SNDs FDCs Biologicals
4. March 2024, Egyptian Drug Authority,Guidance,Management of variables for veterinary preparations
4. March 2024, Egyptian Drug Authority,Draft Guidance,Naming of Human Pharmaceutical Products
4. March 2024, Egyptian Drug Authority,Publication,Impact Analysis for Risk Based Lot Release for Biologics
4. March 2024, Egyptian Drug Authority,Update,The MeDevice database
4. March 2024, European Commission,Factsheet,Factsheet on EU actions on rare diseases
4. March 2024, European Medicines Agency,Infographic,Orphan Medicines in the EU
4. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Access Consortium
4. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK
4. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Established Medicines marketing authorisation application process
4. March 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies
4. March 2024, Medicines and Healthcare products Regulatory Agency,Report,Medicines and Medical Devices Act report 2024
4. March 2024, Medicines and Healthcare products Regulatory Agency,Report,England Rare Diseases Action Plan 2024
4. March 2024, National Institute of Standards and Technology (NIST),Guidance,Version 2.0 of Landmark Cybersecurity Framework
4. March 2024," Health Sciences Authority (HSA), Singapore",Regulation,Proposed Amendments to Regulation 23
4. March 2024," Health Sciences Authority (HSA), Singapore &Korea MFDS and Singapore HAS, Republic of Korea",News,Mutual Recognition Agreement on GMP for Medicinal Products
4. March 2024, Swissmedic,Form,GMP/GCP/GVP/Medical Devices Inspections in Switzerland
4. March 2024, Team NB,Position Paper,Classification of SARS CoV 2
4. March 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Reformatting Product Information: Frequently asked questions
4. March 2024, USA Food & Drug Administration FDA,Guidance,Reporting Amount of Listed Drugs and Biologics Conformance
4. March 2024, USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations for Antibody-Drug Conjugates
4. March 2024, USA Food & Drug Administration FDA,Rule,"Animal Drugs; Approval,  Withdrawal, Change of Sponsor"
4. March 2024, USA Food & Drug Administration FDA,Report,LEADER 3D Public Report of External Engagement Analysis
4. March 2024, USA Food & Drug Administration FDA,Update,Digital Diagnostics: Over-the-Counter (OTC) and Point-of-Care (POC)
4. March 2024, USA Food & Drug Administration FDA,Update,Harmonization & Interoperability Enhancement for Lab.Data (SHIELD)
26. February 2024, ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE (APIC),Guidance,Quality Agreement Guideline & Template
26. February 2024, CDSCO India,Guidance,Neutral Code for manufacturing of Medical Devices for export
26. February 2024, Egyptian Drug Authority,Guidance,Post Market Quality Testing of Biotherapeutic Product in Egypt
26. February 2024, European Commission,Press Release,Medical devices:  Council endorses new measures
26. February 2024, European Commission,News,Possible second call for EU reference laboratories for high-risk IVD
26. February 2024, European Medicines Agency,Meeting,(CHMP) Medicinal Products for Human Use 19-22 February 2024
26. February 2024, International Council for Harmonisation,Training Material,Bioanalytical Method Validation and Study Sample Analysis”
26. February 2024, International Council for Harmonisation,Guidance,ICH Q3C(R9) Guideline reaches Step 4 of the ICH Process
26. February 2024, International Council for Harmonisation,Guidance,ICH E2D(R1) draft Guideline reaches Step 2 of the ICH process
26. February 2024, Medical Device Authority Malaysia,Guidance,Placement of HIV Self-test (HIVST) Kit un Malaysia Market
26. February 2024, Medicines and Healthcare products Regulatory Agency,ATMP Guidance,Characterisation-Capsid Particle Population in rAAV Product
26. February 2024," MEDSAFE, New Zealand",Guidance,Submit an application for pseudoephedrine provisional consent
26. February 2024,Swissmedic,Information Sheet,Medical Device Requirements for CAPA plans
26. February 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,System or procedure packs
26. February 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device labelling obligations
26. February 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Regulation of menstrual cups in Australia
26. February 2024," Therapeutic Goods Administration (TGA), Australia",Pilot Program,Pilot GMP Single Inspection Program
26. February 2024," Therapeutic Goods Administration (TGA), Australia",Checklist,Medical Devices Essential Principles Checklist
26. February 2024," TEAM AB, UK",Announcement,The formation of Team-AB
26. February 2024, USA Food & Drug Administration FDA,Guidance,Select Updates for User Fee Small Business Qualification
26. February 2024, USA Food & Drug Administration FDA,Guidance,Assessing COVID-19 in Outpatients in Clinical Trials of Drugs
26. February 2024, USA Food & Drug Administration FDA,Letter to Industry,Fraudulent Unreliable Data in Premarket Submissions
26. February 2024, USA Food & Drug Administration FDA,News,New Website - Clinical Pharmacology Pediatrics Program
26. February 2024, USA Food & Drug Administration FDA,Report,Office of Generic Drugs 2023 Annual Report
26. February 2024, USA Food & Drug Administration FDA,Update,Diagnostic Data Program
19. February 2024, African Union Development Agency-NEPAD (AUDA-NEPAD)),News,2023 Edition on African Medicines Regulatory Harmonization (AMRH)
19. February 2024, European Commission,EUDAMED,All User guides and templates v2.14
19. February 2024, European Medicines Agency,Catalogues,HMA-EMA real-world data sources and studies
19. February 2024, CDSCO India,Guidance,sampling of drugs cosmetics and medical devices by Drugs Inspectors
19. February 2024, International Medical Device Regulators Forum,Guiding Principles,To Support Medical Device Health Equity
19. February 2024, International Medical Device Regulators Forum,Procedure,IMDRF Terms of Reference
19. February 2024, Medicines and Healthcare products Regulatory Agency,Guidance,The Innovative Devices Access Pathway (IDAP)
19. February 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Implementation of medical devices future regime
19. February 2024, Medicines and Healthcare products Regulatory Agency,Request,For regulators to publish an update on their strategic approach to AI
19. February 2024, Swissmedic,Technical Interpretation,Shipment under Quarantine
19. February 2024, USA Food & Drug Administration FDA,Guidance,Use of Data Monitoring Committees in Clinical Trials
19. February 2024, USA Food & Drug Administration FDA,Guidance,Advanced Manufacturing Technologies Designation Program
19. February 2024, USA Food & Drug Administration FDA,Guidance,Charging for Investigational Drugs Under an IND: Q&A
19. February 2024, USA Food & Drug Administration FDA,Guidance,Product-Specific for Generic Drug Development
19. February 2024, USA Food & Drug Administration FDA,SOPP 8419,Section 505(o)(4) Required Safety Labeling Changes
19. February 2024, USA Food & Drug Administration FDA,Report,FDA Information Technology Operating Plan
19. February 2024, USA Food & Drug Administration FDA,Report,FY23 Drug Safety Priorities Report
19. February 2024, World Health Organisation WHO,List,Medically Important Antimicrobials List for Human Medicine
12. February 2024, European Commission,Guidance,MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature
12. February 2024, European Commission,Survey,Notified Bodies on certifications and applications (MDR/IVDR) (Survey results with data status 31 October 2023)
12. February 2024, European Commission,Video,From Theory to Practice: Implementing the EU Health Technology Assessment Regulation
12. February 2024, European Medicines Agency,Pilot Program,FDA & EMA Parallel Scientific Program for Complex Generics
12. February 2024, European Medicines Agency,Pilot Program,Pharmacovigilance Risk Assessment Committee 5-8 February
12. February 2024, Egyptian Drug Authority,Guidance,Conditions that must be met while submitting files to the Evaluation and Accreditation Department
12. February 2024, Health Canada,Draft guidance,How to interpret ‘significant change’ of a medical device
12. February 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Register a homeopathic medicine
12. February 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Regulating medical devices in the UK
12. February 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Guidance: Implementing the UK’s AI regulatory principles
12. February 2024, Medical Device Authority Malaysia,Subscription,MDA Regulatory Information Subscription (MDA-RIS)
12. February 2024, MedTech Europe,Joint Statement,Supporting Use of eIFU in the medical devices sector
12. February 2024, Swissmedic,Journal,Swissmedic Journal
12. February 2024, Swissmedic,Guidance,Industry Electronic exchange of ICSRs through PV Gateway
12. February 2024, Swissmedic,News,swissdamed – Swiss Database on Medical Devices
12. February 2024, USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Q&A
12. February 2024, USA Food & Drug Administration FDA,Guidance,Reporting Amount of Listed Drugs and Biological Products
12. February 2024, USA Food & Drug Administration FDA,Final Rule,Biologics License Applications and Master Files
12. February 2024, USA Food & Drug Administration FDA,Guidance,Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or API Under Section 506C of the FD&C Act
12. February 2024, USA Food & Drug Administration FDA,Report,Office of Digital Transformation Annual Report
12. February 2024, USA Food & Drug Administration FDA,Report,Office of Clinical Pharmacology Annual Report
12. February 2024, USA Food & Drug Administration FDA,Report,SOPP 8401.2: Administrative Processing of BLA and NDA Supplements
5. February 2024, European Commission,MDCG Template,Device Specific Vigilance Guidance (DSVG)
5. February 2024, European Commission,MDCG Template,DSVG 01 Devices for Cardiac Ablation
5. February 2024, European Commission,MDCG Template,DSVG 02 Coronary Stents and associated delivery systems
5. February 2024, European Commission,MDCG Template,DSVG 03 Cardiac Implantable Electronic Devices (CIEDs)
5. February 2024, European Commission,MDCG Template,DSVG 04 Breast Implants
5. February 2024, European Commission,EUDAMED,Playground 3.7.0 has been deployed.
5. February 2024, European Medicines Agency,News,CTIS newsflash - 26 January 2024 (europa.eu)
5. February 2024, European Medicines Agency,News,One year left to transition to the new Clinical Trials Information System
5. February 2024, European Medicines Agency,Guidance,ICH Q14 Analytical procedure development - Scientific guideline
5. February 2024, European Medicines Agency,Guidance,Production API and Registration Process
5. February 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies - GOV.UK (www.gov.uk)
5. February 2024, Medical Device Authority Malaysia,Guidance,GENERAL MEDICAL DEVICE – GROUPING
5. February 2024, Medical Device Authority Malaysia,Guidance,IMPORTATION OF MEDICAL DEVICE FOR PERSONAL USE
5. February 2024, Medical Device Authority Malaysia,Guidance,POST MARKET INFORMATION EXCHANGE ASEAN STATES
5. February 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising personalised medical devices
5. February 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,eCTD AU module 1 and regional information
5. February 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Special Access Scheme (SAS) online system guidance
5. February 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Authorised Prescriber Scheme online system guidance
5. February 2024," Health Sciences Authority (HSA), Singapore",Updates,reclassified medicines
5. February 2024, International Medical Device Regulators Forum,Consultation,SaMD: Considerations for Device and Risk Characterization
5. February 2024, Swissmedic,Guidance,Product information for human medicinal products
5. February 2024, Swissmedic,Guidance,Variations and extensions HAM
5. February 2024, USA Food & Drug Administration FDA,Final Rule,Quality Management System Regulation
5. February 2024, USA Food & Drug Administration FDA,Guidance,Collection of Race and Ethnicity Data in Clinical Trials
5. February 2024, USA Food & Drug Administration FDA,Guidance,Human Gene Therapy Products Incorporating Genome Editing
5. February 2024, USA Food & Drug Administration FDA,Guidance,Development of Chimeric Antigen Receptor (CAR) T Cell Products
5. February 2024, USA Food & Drug Administration FDA,Guidance,Postmarketing Safety Surveillance of Drug and Biological Products
5. February 2024, USA Food & Drug Administration FDA,News,Reclassification Process for Most High Risk IVDs
5. February 2024, World Health Organisation WHO,Report,Imagining futures of 3D bioprinting
29. January 2024, European Commission,News,Proposal to extend transition periods for certain IVDs
29. January 2024, European Medicines Agency,Guidance,Major update of the SME user guide
29. January 2024, European Medicines Agency,Guidance,The clinical evaluation of anticancer medicinal products
29. January 2024, European Medicines Agency,Report,Veterinary medicines: Highlights of 2023
29. January 2024, European Medicines Agency,Meeting highlights,Committee for Medicinal Products for Human Use (CHMP)
29. January 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Annual Reports
29. January 2024, International Society for Pharmaceutical Engineering (ISPE),Guidance,Recombinant AAV Comparability & Lifecycle Management
29. January 2024, International Society for Pharmaceutical Engineering (ISPE),Guidance,Allogeneic Cell Therapy
29. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies
29. January 2024, Global Fund,Guidance,Q&A Quality Assurance Policy for Pharmaceutical Products and  Medical Devices (including IVDand Core Personal Protective Equipment
29. January 2024, International Accreditation Forum (IAF),Guidance,(IAF MDN) Including Medical Device Risk Classifications
29. January 2024, Organisation for Economic Co-operation and Development,Publication,Collective action for responsible AI in health
29. January 2024, USA Food & Drug Administration FDA,SOPP 8101.1,Regulatory Meetings for Drugs and Biological Products
29. January 2024, USA Food & Drug Administration FDA,Guidance,Characterization of Metallic Coatings and/or Calcium Phosphate Coatings on Orthopedic Devices
29. January 2024, USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Q&A
29. January 2024, USA Food & Drug Administration FDA,Guidance,Revising ANDA Labeling Following Revision of the RLD Labeling Guidance for Industry: Guidance for Industry
29. January 2024, USA Food & Drug Administration FDA,Guidance,ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs: Guidance for Industry
29. January 2024, USA Food & Drug Administration FDA,Guidance,CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products
29. January 2024, USA Food & Drug Administration FDA,Best Practices,Postmarketing Safety Surveillance of Human Drug and Biological Products; Final Document; Availability
29. January 2024, USA Food & Drug Administration FDA,Update,ASCA-Accredited Testing Laboratories
29. January 2024, USA Food & Drug Administration FDA,News,FDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience
29. January 2024, USA Food & Drug Administration FDA,Website,For Healthcare Professionals | FDA’s Examples of Drugs that Interact with CYP Enzymes and Transporter Systems
22. January 2024, European Commission,Plan,Joint implementation and preparedness plan for Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)
22. January 2024, European Commission,Data Act,Harmonised rules on fair access to and use of data Overview: Language requirements for manufacturers of medical devices
22. January 2024, European Medicines Agency,Report,Human medicines: highlights of 2023
22. January 2024, European Medicines Agency,Report,Big Data Steering Group (BDSG): 2023 report
22. January 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,"Reclassification of medical devices in direct contact with the heart, central circulatory and central nervous systems"
22. January 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of medical devices that administer medicines or biologicals by inhalation
22. January 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of medical devices that are substances to be introduced into the body or applied to and absorbed by the skin
22. January 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of spinal implantable medical devices
22. January 2024," Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of active medical devices with a diagnostic function
22. January 2024, Egyptian Drug Authority,Guidance,Registration of Human Pharmaceutical Products
22. January 2024, Egyptian Drug Authority,Draft Guidance,Examination of human use product files
22. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device
22. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies
22. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK
22. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,MHRA launches new fees calculator
22. January 2024, USA Food & Drug Administration FDA,Important Info,Final Rule to Amend the Mammography Quality Standards Act
22. January 2024, USA Food & Drug Administration FDA,Pilot Program,Accelerate Development of Rare Disease Therapies
22. January 2024, USA Food & Drug Administration FDA,Report,CDRH 2023 Annual Report
22. January 2024, USA Food & Drug Administration FDA,Deadline,Advancing Real-World Evidence Program submission deadline
22. January 2024, USA Food & Drug Administration FDA,Statement,FDA and CMS: Accurate and Reliable Diagnostic Tests
22. January 2024, Swissmedic,Guidance,Document Authorisation according to Art. 14 para. 1 abis-quater TPA
22. January 2024, Swissmedic,Guidance,Author. of immuno. veterinary medicinal prod. epizootic outbreak
22. January 2024, Swissmedic,Guidance,Authorisation of human medicinal products under Art. 13 TPA
22. January 2024, Swissmedic,Guidance,Fast-track authorisation procedure
22. January 2024, Swissmedic,Guidance,Temporary authorisation of human medicinal products
22. January 2024, Swissmedic,Guidance,Authorisation of human medicinal product known API
15. January 2024, European Commission,Guidelines,Medical imaging studies and reports
15. January 2024, European Commission,Dashboard,Study supporting the monitoring of availability of medical devices
15. January 2024, European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee (PRAC)
15. January 2024, Egyptian Drug Authority,Guidelines,Nuclear and Radiation Safety and Nuclear Pharmacy Practice
15. January 2024, Egyptian Drug Authority,Updates,"Requirements of centers, bioequivalence and solubility studies"
15. January 2024, Medicines and Healthcare products Regulatory Agency,Standard,Implementation of medical devices future regime
15. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active UK substances for use in EEA and Northern Ireland
15. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Borderline products: how to tell if your product is a medicine
15. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Register medical devices to place on the market
15. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Labelling and packaging-Windsor Framework
15. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Export Medical Devices
15. January 2024, USA Food & Drug Administration FDA,News,Vaporized Hydrogen Peroxide for Medical Device Sterilization
15. January 2024, USA Food & Drug Administration FDA,News,New Drug Therapy Approvals 2023
15. January 2024, USA Food & Drug Administration FDA,News,New Webpage for Searching Pharmaceutical Quality Documents
15. January 2024, USA Food & Drug Administration FDA,Guidance,510(k) Submissions for Devices Labeled as Sterile
15. January 2024, USA Food & Drug Administration FDA,Guidance,Q5A(R2) Viral Safety Evaluation of Biotechnology Products
15. January 2024, USA Food & Drug Administration FDA,Guidance,Requests for Reconsideration at the Division Level Under GDUFA
15. January 2024, USA Food & Drug Administration FDA,Forms,Tools for Cosmetic Product Facility Registration and Product Listing
15. January 2024, USA Food & Drug Administration FDA,SOPP,Administrative Processing of Original Biologics License Applications Report: CTTI and FDA share strategies “CTTI Report 2024”
15. January 2024, USA Food & Drug Administration FDA,Report,Congressional Research Service – FDA Regulation of Medical Devices
15. January 2024, USA Food & Drug Administration FDA,Report,CDER Annual Report 2023
15. January 2024, USA Food & Drug Administration FDA,QMSR News,Medical Devices; Quality System Regulation Amendments
15. January 2024, ISO (International Organization for Standardization),Standard,"ISO Update December 1, 2023 to January 1, 2024"
15. January 2024, Swissmedic,Guidance,Application licence for medicinal products or TpP/GT/GMO
15. January 2024, Swissmedic,Guidance,Verzicht Betriebsbewilligung Arzneimittel (inkl. Blut) /TpP/GT/GVO
15. January 2024, Swissmedic,Form,"Applications for, discontinuation of an establishment licence"
15. January 2024, Swissmedic,Announcement,Certification from the former notified body ECM (Aachen DE)
15. January 2024, Ministry of Health Sciences Authority Singapore,Fees,Regulatory fee revision for health products
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Operational Information Sharing
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a traditional herbal registration (THR)
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a variation to your marketing authorisation
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,150-day assessment for national applications for
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Register a homeopathic medicine
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Unfettered Access Procedure for marketing authorisations approved in Northern Ireland
8. January 2024, Medicines and Healthcare products Regulatory Agency,Guidance,Written Confirmations for export to EEA and Northern Ireland
8. January 2024, Medicines and Healthcare products Regulatory Agency,News,International Recognition Procedure (IRP) goes live
8. January 2024, Medicines and Healthcare products Regulatory Agency,News,The British Pharmacopoeia (BP) 2024 edition now legally effective
8. January 2024, CDSCO India,News,Launching of National Single Window System (NSWS) Portal
8. January 2024, USA Food & Drug Administration FDA,Letter to Industry,Medical Device Transition to Electronic Export Documents
8. January 2024, USA Food & Drug Administration FDA,Update,ASCA-Accredited Testing Laboratories
8. January 2024, Medical Device Authority Malaysia,Important Notice,Expiry of CAB Registration for Newera International
8. January 2024, Swissmedic,Guidance,Swiss Single Registration Number – CHRN
8. January 2024, Swissmedic,Guidance,Export Certificates
8. January 2024, Swissmedic,Guidance,Terms of Reference - Round Table on Medical Technology
8. January 2024, Swissmedic,Guidance,Organisatiion Regulations: Organisationsreglement Swissmedic
8. January 2024, Swissmedic,Directory,Overview of documents to be submitted
8. January 2024, Swissmedic,Directory,List countries with comparable control of human medicinal products
8. January 2024, Swissmedic,Guidance,Packaging for human medicinal products
8. January 2024, Swissmedic,Form,New authorisation of human medicinal products
8. January 2024, Swissmedic,Guidance,Guidance document Authorisation of Asian medicinal products)
8. January 2024, Swissmedic,Form,Import of a human medicinal product(parallel import)
8. January 2024, Swissmedic,Guidance,Import of a human medicinal product (parallel import)
8. January 2024, Saudi Food & Drug Authority,Guidance,Requirements for Clinical Trials of Medical Devices
8. January 2024, Department of Health The Government of the Hong Kong,Technical Reference,Artificial Intelligence Medical Devices (AI-MD)
